https://www.medxy.ai/news/ja/ibdome%EF%BC%9A%E5%88%86%E5%AD%90%E3%83%BB%E7%97%85%E7%90%86%E7%B5%84%E7%B9%94%E3%83%BB%E8%87%A8%E5%BA%8A%E3%83%87%E3%83%BC%E3%82%BF%E3%82%92%E7%B5%B1%E5%90%88%E3%81%97%E3%80%81%E7%82%8E%E7%97%87 2026-07-03T20:04:48.000Z daily 0.75 https://www.medxy.ai/news/zh/ibdome%EF%BC%9A%E6%95%B4%E5%90%88%E5%88%86%E5%AD%90%E3%80%81%E7%BB%84%E7%BB%87%E7%97%85%E7%90%86%E5%AD%A6%E4%B8%8E%E4%B8%B4%E5%BA%8A%E6%95%B0%E6%8D%AE%EF%BC%8C%E9%87%8D%E5%A1%91%E7%82%8E%E7%97%87 2026-07-03T20:04:40.000Z daily 0.75 https://www.medxy.ai/news/impact-of-acetaldehyde-metabolism-on-alcohol-related-inflammatory-bowel-disease-risk-a-precision-medicine-perspective 2026-07-03T17:48:48.000Z daily 0.75 https://www.medxy.ai/news/vi/chuyen-hoa-acetaldehyde-anh-huong-the-nao-den-nguy-co-benh-viem-ruot-do-ruou-goc-nhin-tu-y-hoc-chinh-xac 2026-07-03T17:49:19.000Z daily 0.75 https://www.medxy.ai/news/ja/%E3%82%A2%E3%82%BB%E3%83%88%E3%82%A2%E3%83%AB%E3%83%87%E3%83%92%E3%83%89%E4%BB%A3%E8%AC%9D%E3%81%8C%E5%B7%A6%E5%8F%B3%E3%81%99%E3%82%8B%E9%A3%B2%E9%85%92%E9%96%A2%E9%80%A3%E7%82%8E%E7%97%87%E6%80%A7 2026-07-03T20:04:27.000Z daily 0.75 https://www.medxy.ai/news/zh/%E4%B9%99%E9%86%9B%E4%BB%A3%E8%B0%A2%E5%A6%82%E4%BD%95%E5%BD%B1%E5%93%8D%E9%85%92%E7%B2%BE%E7%9B%B8%E5%85%B3%E7%82%8E%E7%97%87%E6%80%A7%E8%82%A0%E7%97%85%E9%A3%8E%E9%99%A9%EF%BC%9A%E7%B2%BE%E5%87%86 2026-07-03T20:04:21.000Z daily 0.75 https://www.medxy.ai/news/global-insights-into-masld-predictors-of-fibrosis-clinical-events-and-mortality-from-the-global-masld-study 2026-07-03T18:08:31.000Z daily 0.75 https://www.medxy.ai/news/vi/masld-tren-pham-vi-toan-cau-nhung-yeu-to-du-bao-xo-hoa-bien-co-lam-sang-va-tu-vong-tu-nghien-cuu-global-masld 2026-07-03T20:04:12.000Z daily 0.75 https://www.medxy.ai/news/ja/masld%E3%81%AE%E5%9B%BD%E9%9A%9B%E5%AE%9F%E6%85%8B%E3%82%92%E8%A7%A3%E6%98%8E%EF%BC%9Aglobal-masld%E7%A0%94%E7%A9%B6%E3%81%8C%E7%A4%BA%E3%81%97%E3%81%9F%E7%B7%9A%E7%B6%AD%E5%8C%96%E3%83%BB%E8%87%A8 2026-07-03T20:04:03.000Z daily 0.75 https://www.medxy.ai/news/zh/global-masld%E7%A0%94%E7%A9%B6%E6%8F%AD%E7%A4%BAmasld%E7%BA%A4%E7%BB%B4%E5%8C%96%E3%80%81%E4%B8%B4%E5%BA%8A%E7%BB%93%E5%B1%80%E4%B8%8E%E6%AD%BB%E4%BA%A1%E9%A3%8E%E9%99%A9%E7%9A%84%E5%85%A8%E7%90%83 2026-07-03T20:03:48.000Z daily 0.75 https://www.medxy.ai/news/ebola-virus-in-pregnancy-current-insights-and-clinical-implications-during-the-dr-congo-outbreak 2026-07-03T19:09:32.000Z daily 0.75 https://www.medxy.ai/news/vi/vi-rut-ebola-trong-thai-ky-cap-nhat-moi-va-y-nghia-lam-sang-trong-dot-bung-phat-tai-drc 2026-07-03T20:03:19.000Z daily 0.75 https://www.medxy.ai/news/ja/%E5%A6%8A%E5%A8%A0%E4%B8%AD%E3%81%AE%E3%82%A8%E3%83%9C%E3%83%A9%E3%82%A6%E3%82%A4%E3%83%AB%E3%82%B9%E6%84%9F%E6%9F%93%E7%97%87%EF%BC%9Adr%E3%82%B3%E3%83%B3%E3%82%B4%E6%B5%81%E8%A1%8C%E3%82%92%E8%B8%8F 2026-07-03T20:03:08.000Z daily 0.75 https://www.medxy.ai/news/zh/%E5%A6%8A%E5%A8%A0%E6%9C%9F%E5%9F%83%E5%8D%9A%E6%8B%89%E7%97%85%E6%AF%92%EF%BC%9A%E5%88%9A%E6%9E%9C%EF%BC%88%E9%87%91%EF%BC%89%E6%9A%B4%E5%8F%91%E8%83%8C%E6%99%AF%E4%B8%8B%E7%9A%84%E6%9C%80%E6%96%B0 2026-07-03T20:02:56.000Z daily 0.75 https://www.medxy.ai/news/global-variations-in-concurrent-hysterectomy-during-risk-reducing-surgery-for-brca1-2-carriers-an-integrated-quantitative-and-qualitative-analysis 2026-07-03T20:10:13.000Z daily 0.75 https://www.medxy.ai/news/vi/bien-thien-toan-cau-ve-cat-tu-cung-dong-thoi-trong-phau-thuat-giam-nguy-co-o-nguoi-mang-brca1-2-phan-tich-dinh-luong-va-dinh-tinh-tich-hop 2026-07-04T07:46:00.000Z daily 0.75 https://www.medxy.ai/news/ja/brca1-2%E4%BF%9D%E6%9C%89%E8%80%85%E3%81%AE%E3%83%AA%E3%82%B9%E3%82%AF%E4%BD%8E%E6%B8%9B%E6%89%8B%E8%A1%93%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E4%BD%B5%E6%96%BD%E5%AD%90%E5%AE%AE%E6%91%98%E5%87%BA 2026-07-04T07:45:52.000Z daily 0.75 https://www.medxy.ai/news/zh/brca1-2%E6%90%BA%E5%B8%A6%E8%80%85%E9%A3%8E%E9%99%A9%E9%99%8D%E4%BD%8E%E6%89%8B%E6%9C%AF%E4%B8%AD%E5%90%8C%E6%9C%9F%E5%AD%90%E5%AE%AB%E5%88%87%E9%99%A4%E6%9C%AF%E7%9A%84%E5%85%A8%E7%90%83%E5%B7%AE 2026-07-04T07:45:42.000Z daily 0.75 https://www.medxy.ai/news/first-trimester-screening-for-preterm-preeclampsia-in-the-united-kingdom-evaluating-the-cost-effectiveness-of-the-fmf-strategy-versus-nice-guidelines 2026-07-04T07:47:10.000Z daily 0.75 https://www.medxy.ai/news/vi/sang-loc-tien-san-giat-non-thang-o-tam-ca-nguyet-thu-nhat-tai-vuong-quoc-anh-danh-gia-hieu-qua-chi-phi-cua-chien-luoc-fmf-so-voi-huong-dan-nice 2026-07-04T07:48:59.000Z daily 0.75 https://www.medxy.ai/news/ja/%E8%8B%B1%E5%9B%BD%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E6%97%A9%E7%94%A3%E5%9E%8B%E5%A6%8A%E5%A8%A0%E9%AB%98%E8%A1%80%E5%9C%A7%E8%85%8E%E7%97%87%E3%81%AE%E5%A6%8A%E5%A8%A0%E5%88%9D%E6%9C%9F%E3%82%B9 2026-07-04T07:49:19.000Z daily 0.75 https://www.medxy.ai/news/circulating-tumor-dna-status-and-adjuvant-chemotherapy-in-resected-colorectal-liver-metastases 2026-07-04T07:56:45.000Z daily 0.75 https://www.medxy.ai/news/vi/ctdna-luu-hanh-sau-phau-thuat-va-vai-tro-cua-hoa-tri-bo-tro-trong-di-can-gan-tu-ung-thu-dai-truc-trang-da-cat-bo 2026-07-04T07:57:56.000Z daily 0.75 https://www.medxy.ai/news/ja/%E5%88%87%E9%99%A4%E5%BE%8Cctdna%E3%81%A7%E8%A6%8B%E6%A5%B5%E3%82%81%E3%82%8B%E5%A4%A7%E8%85%B8%E7%99%8C%E8%82%9D%E8%BB%A2%E7%A7%BB%E3%81%B8%E3%81%AE%E8%A1%93%E5%BE%8C%E8%A3%9C%E5%8A%A9%E5%8C%96 2026-07-04T07:58:13.000Z daily 0.75 https://www.medxy.ai/news/harnessing-cardiac-ct-radiomics-of-epicardial-fat-for-early-heart-failure-prediction 2026-07-04T08:09:02.000Z daily 0.75 https://www.medxy.ai/news/pass-a-simplified-clinical-tool-to-differentiate-acquired-aplastic-anemia-from-inherited-bone-marrow-failure-syndromes-in-adults 2026-07-04T10:38:15.000Z daily 0.75 https://www.medxy.ai/news/vi/pass-cong-cu-lam-sang-don-gian-giup-phan-biet-thieu-mau-bat-san-mac-phai-voi-cac-hoi-chung-suy-tuy-xuong-di-truyen-o-nguoi-lon 2026-07-04T10:43:41.000Z daily 0.75 https://www.medxy.ai/news/ja/pass%EF%BC%9A%E6%88%90%E4%BA%BA%E3%81%AE%E5%BE%8C%E5%A4%A9%E6%80%A7%E5%86%8D%E7%94%9F%E4%B8%8D%E8%89%AF%E6%80%A7%E8%B2%A7%E8%A1%80%E3%81%A8%E9%81%BA%E4%BC%9D%E6%80%A7%E9%AA%A8%E9%AB%84%E4%B8%8D 2026-07-04T10:43:26.000Z daily 0.75 https://www.medxy.ai/news/zh/pass%EF%BC%9A%E7%94%A8%E4%BA%8E%E6%88%90%E4%BA%BA%E8%8E%B7%E5%BE%97%E6%80%A7%E5%86%8D%E7%94%9F%E9%9A%9C%E7%A2%8D%E6%80%A7%E8%B4%AB%E8%A1%80%E4%B8%8E%E9%81%97%E4%BC%A0%E6%80%A7%E9%AA%A8%E9%AB%93 2026-07-04T10:41:16.000Z daily 0.75 https://www.medxy.ai/news/reducing-procedure-time-with-ct-guided-catheter-ablation-in-ventricular-tachycardia-insights-from-the-ineurheart-trial 2026-07-04T20:30:42.000Z daily 0.75 https://www.medxy.ai/news/vi/triet-dot-nhip-nhanh-that-duoi-huong-dan-ct-rut-ngan-thoi-gian-thu-thuat-theo-du-lieu-tu-thu-nghiem-ineurheart 2026-07-04T22:08:46.000Z daily 0.75 https://www.medxy.ai/news/ja/ct%E3%82%AC%E3%82%A4%E3%83%89%E4%B8%8B%E3%82%AB%E3%83%86%E3%83%BC%E3%83%86%E3%83%AB%E3%82%A2%E3%83%96%E3%83%AC%E3%83%BC%E3%82%B7%E3%83%A7%E3%83%B3%E3%81%A7%E5%BF%83%E5%AE%A4%E9%A0%BB%E6%8B%8D%E6%B2%BB 2026-07-04T22:08:42.000Z daily 0.75 https://www.medxy.ai/news/zh/ct%E5%BC%95%E5%AF%BC%E5%AF%BC%E7%AE%A1%E6%B6%88%E8%9E%8D%E8%83%BD%E5%90%A6%E8%AE%A9%E5%AE%A4%E6%80%A7%E5%BF%83%E5%8A%A8%E8%BF%87%E9%80%9F%E6%B2%BB%E7%96%97%E6%9B%B4%E9%AB%98%E6%95%88%EF%BC%9F 2026-07-04T22:08:37.000Z daily 0.75 https://www.medxy.ai/news/two-years-of-menaquinone-7-supplementation-attenuates-coronary-artery-calcification-progression-evidence-from-randomized-clinical-trials 2026-07-04T22:08:31.000Z daily 0.75 https://www.medxy.ai/news/vi/two-years-of-menaquinone-7-supplementation-attenuates-coronary-artery-calcification-progression-evidence-from-randomized-clinical-trials-2 2026-07-07T09:14:26.000Z daily 0.75 https://www.medxy.ai/news/ja/two-years-of-menaquinone-7-supplementation-attenuates-coronary-artery-calcification-progression-evidence-from-randomized-clinical-trials-3 2026-07-07T09:14:30.000Z daily 0.75 https://www.medxy.ai/news/zh/%E8%A1%A5%E5%85%85%E7%94%B2%E8%90%98%E9%86%8C-7%E4%B8%A4%E5%B9%B4%E5%8F%AF%E5%87%8F%E7%BC%93%E5%86%A0%E7%8A%B6%E5%8A%A8%E8%84%89%E9%92%99%E5%8C%96%E8%BF%9B%E5%B1%95%EF%BC%9A%E9%9A%8F%E6%9C%BA%E4%B8%B4 2026-07-04T22:07:21.000Z daily 0.75 https://www.medxy.ai/news/declining-trends-in-impaired-awareness-of-hypoglycemia-and-severe-hypoglycemia-in-youth-with-type-1-diabetes-over-two-decades 2026-07-04T20:42:47.000Z daily 0.75 https://www.medxy.ai/news/vi/declining-trends-in-impaired-awareness-of-hypoglycemia-and-severe-hypoglycemia-in-youth-with-type-1-diabetes-over-two-decades-2 2026-07-07T09:14:16.000Z daily 0.75 https://www.medxy.ai/news/pathophysiology-based-classification-of-male-infertility-transforming-diagnosis-and-treatment-through-comprehensive-phenotyping 2026-07-04T20:47:41.000Z daily 0.75 https://www.medxy.ai/news/vi/pathophysiology-based-classification-of-male-infertility-transforming-diagnosis-and-treatment-through-comprehensive-phenotyping-4 2026-07-07T09:14:09.000Z daily 0.75 https://www.medxy.ai/news/ja/pathophysiology-based-classification-of-male-infertility-transforming-diagnosis-and-treatment-through-comprehensive-phenotyping-2 2026-07-07T09:14:02.000Z daily 0.75 https://www.medxy.ai/news/zh/pathophysiology-based-classification-of-male-infertility-transforming-diagnosis-and-treatment-through-comprehensive-phenotyping-3 2026-07-07T09:14:05.000Z daily 0.75 https://www.medxy.ai/news/baseline-and-longitudinal-joint-associations-of-alcohol-consumption-and-obesity-with-diabetes-risk-evaluating-multiplicative-and-additive-interactions 2026-07-04T21:59:21.000Z daily 0.75 https://www.medxy.ai/news/vi/baseline-and-longitudinal-joint-associations-of-alcohol-consumption-and-obesity-with-diabetes-risk-evaluating-multiplicative-and-additive-interactions-2 2026-07-07T09:13:52.000Z daily 0.75 https://www.medxy.ai/news/ja/baseline-and-longitudinal-joint-associations-of-alcohol-consumption-and-obesity-with-diabetes-risk-evaluating-multiplicative-and-additive-interactions-3 2026-07-07T09:13:55.000Z daily 0.75 https://www.medxy.ai/news/impact-of-hypothyroidism-on-short-term-and-long-term-outcomes-of-coronary-artery-bypass-graft-surgery 2026-07-04T22:10:46.000Z daily 0.75 https://www.medxy.ai/news/vi/suy-giap-anh-huong-the-nao-den-ket-cuc-ngan-han-va-dai-han-sau-phau-thuat-bac-cau-dong-mach-vanh 2026-07-04T22:12:49.000Z daily 0.75 https://www.medxy.ai/news/decompressive-craniectomy-vs-standard-craniotomy-for-large-acute-epidural-hematoma-with-tentorial-herniation-insights-from-the-predict-aedh-trial-in-china 2026-07-04T22:23:07.000Z daily 0.75 https://www.medxy.ai/news/vi/decompressive-craniectomy-vs-standard-craniotomy-for-large-acute-epidural-hematoma-with-tentorial-herniation-insights-from-the-predict-aedh-trial-in-china-2 2026-07-07T09:13:37.000Z daily 0.75 https://www.medxy.ai/news/ja/decompressive-craniectomy-vs-standard-craniotomy-for-large-acute-epidural-hematoma-with-tentorial-herniation-insights-from-the-predict-aedh-trial-in-china-3 2026-07-07T09:13:40.000Z daily 0.75 https://www.medxy.ai/news/zh/decompressive-craniectomy-vs-standard-craniotomy-for-large-acute-epidural-hematoma-with-tentorial-herniation-insights-from-the-predict-aedh-trial-in-china-4 2026-07-07T09:13:43.000Z daily 0.75 https://www.medxy.ai/news/long-term-neurological-sequelae-in-adult-survivors-of-ebola-virus-disease-insights-from-a-7-year-liberian-cohort-study 2026-07-05T08:06:18.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-neurological-sequelae-in-adult-survivors-of-ebola-virus-disease-insights-from-a-7-year-liberian-cohort-study-2 2026-07-07T09:13:17.000Z daily 0.75 https://www.medxy.ai/news/ja/long-term-neurological-sequelae-in-adult-survivors-of-ebola-virus-disease-insights-from-a-7-year-liberian-cohort-study-3 2026-07-07T09:13:21.000Z daily 0.75 https://www.medxy.ai/news/zh/long-term-neurological-sequelae-in-adult-survivors-of-ebola-virus-disease-insights-from-a-7-year-liberian-cohort-study-4 2026-07-07T09:13:25.000Z daily 0.75 https://www.medxy.ai/news/unraveling-the-link-between-cortical-microinfarcts-and-superficial-siderosis-in-cerebral-amyloid-angiopathy 2026-07-05T09:01:54.000Z daily 0.75 https://www.medxy.ai/news/vi/unraveling-the-link-between-cortical-microinfarcts-and-superficial-siderosis-in-cerebral-amyloid-angiopathy-2 2026-07-07T09:13:07.000Z daily 0.75 https://www.medxy.ai/news/accelerating-care-in-intracerebral-hemorrhage-the-impact-of-mobile-stroke-units 2026-07-05T09:03:47.000Z daily 0.75 https://www.medxy.ai/news/decoding-the-gut-brain-axis-how-early-life-stress-shapes-gut-motility-and-pain-through-neural-pathways 2026-07-05T09:05:11.000Z daily 0.75 https://www.medxy.ai/news/vi/decoding-the-gut-brain-axis-how-early-life-stress-shapes-gut-motility-and-pain-through-neural-pathways-2 2026-07-07T09:12:53.000Z daily 0.75 https://www.medxy.ai/news/ja/decoding-the-gut-brain-axis-how-early-life-stress-shapes-gut-motility-and-pain-through-neural-pathways-3 2026-07-07T09:12:56.000Z daily 0.75 https://www.medxy.ai/news/zh/decoding-the-gut-brain-axis-how-early-life-stress-shapes-gut-motility-and-pain-through-neural-pathways-4 2026-07-07T09:12:59.000Z daily 0.75 https://www.medxy.ai/news/glucagon-like-peptide-1-receptor-agonists-versus-dipeptidyl-peptidase-4-inhibitors-following-liver-resection-for-hepatocellular-carcinoma-in-type-2-diabetes-insights-from-a-target-trial-emulation-stu 2026-07-05T09:07:16.000Z daily 0.75 https://www.medxy.ai/news/vi/glucagon-like-peptide-1-receptor-agonists-versus-dipeptidyl-peptidase-4-inhibitors-following-liver-resection-for-hepatocellular-carcinoma-in-type-2-diabetes-insights-from-a-target-trial-emulation-st-2 2026-07-07T09:12:44.000Z daily 0.75 https://www.medxy.ai/news/development-and-validation-of-a-noninvasive-score-for-at-risk-metabolic-dysfunction-associated-steatohepatitis-in-individuals-with-obesity-undergoing-bariatric-surgery 2026-07-05T09:09:14.000Z daily 0.75 https://www.medxy.ai/news/nitrous-oxide-as-an-effective-analgesic-in-office-operative-hysteroscopy-insights-from-a-randomized-controlled-trial 2026-07-05T09:12:19.000Z daily 0.75 https://www.medxy.ai/news/assessing-validity-of-essentials-in-minimally-invasive-gynecologic-surgery-correlation-with-global-operative-assessment-of-laparoscopic-skills 2026-07-05T09:14:50.000Z daily 0.75 https://www.medxy.ai/news/vi/danh-gia-do-gia-tri-cua-bai-thi-ky-nang-cot-loi-trong-phau-thuat-phu-khoa-xam-lan-toi-thieu-tuong-quan-voi-global-operative-assessment-of-laparoscopic-skills 2026-07-05T09:15:41.000Z daily 0.75 https://www.medxy.ai/news/evaluating-the-impact-of-a-structured-caesarean-reduction-strategy-on-perinatal-outcomes-insights-from-a-decade-long-italian-study 2026-07-05T09:18:37.000Z daily 0.75 https://www.medxy.ai/news/vi/evaluating-the-impact-of-a-structured-caesarean-reduction-strategy-on-perinatal-outcomes-insights-from-a-decade-long-italian-study-2 2026-07-07T09:12:23.000Z daily 0.75 https://www.medxy.ai/news/ja/evaluating-the-impact-of-a-structured-caesarean-reduction-strategy-on-perinatal-outcomes-insights-from-a-decade-long-italian-study-3 2026-07-07T09:12:26.000Z daily 0.75 https://www.medxy.ai/news/zh/evaluating-the-impact-of-a-structured-caesarean-reduction-strategy-on-perinatal-outcomes-insights-from-a-decade-long-italian-study-4 2026-07-07T09:12:32.000Z daily 0.75 https://www.medxy.ai/news/advancing-precision-prognosis-in-high-grade-serous-ovarian-cancer-via-multi-time-point-radiomics-and-clinical-data-integration 2026-07-05T09:21:06.000Z daily 0.75 https://www.medxy.ai/news/advancing-microsurgical-reconstruction-real-world-evaluation-of-the-symani-surgical-system-in-the-primo-study 2026-07-05T09:24:01.000Z daily 0.75 https://www.medxy.ai/news/vi/advancing-microsurgical-reconstruction-real-world-evaluation-of-the-symani-surgical-system-in-the-primo-study-2 2026-07-07T09:12:03.000Z daily 0.75 https://www.medxy.ai/news/ja/advancing-microsurgical-reconstruction-real-world-evaluation-of-the-symani-surgical-system-in-the-primo-study-3 2026-07-07T09:12:09.000Z daily 0.75 https://www.medxy.ai/news/zh/advancing-microsurgical-reconstruction-real-world-evaluation-of-the-symani-surgical-system-in-the-primo-study-4 2026-07-07T09:12:13.000Z daily 0.75 https://www.medxy.ai/news/reevaluating-lumpectomy-margin-thresholds-in-hr-positive-dcis-insights-from-the-nrg-oncology-nsabp-b-35-trial 2026-07-05T15:40:32.000Z daily 0.75 https://www.medxy.ai/news/vi/reevaluating-lumpectomy-margin-thresholds-in-hr-positive-dcis-insights-from-the-nrg-oncology-nsabp-b-35-trial-2 2026-07-07T09:11:40.000Z daily 0.75 https://www.medxy.ai/news/ja/reevaluating-lumpectomy-margin-thresholds-in-hr-positive-dcis-insights-from-the-nrg-oncology-nsabp-b-35-trial-3 2026-07-07T09:11:47.000Z daily 0.75 https://www.medxy.ai/news/zh/hr%E9%98%B3%E6%80%A7dcis%E4%BF%9D%E4%B9%B3%E5%88%87%E7%BC%98%E9%9C%80%E8%A6%81%E5%A4%9A%E5%AE%BD%EF%BC%9F-nrg-oncology-nsabp-b-35%E8%AF%95%E9%AA%8C%E5%B8%A6%E6%9D%A5%E7%9A%84%E6%96%B0 2026-07-05T16:45:34.000Z daily 0.75 https://www.medxy.ai/news/fistulotomy-with-primary-sphincteroplasty-for-complex-anal-fistulas-balancing-cure-with-continence-preservation 2026-07-05T15:48:50.000Z daily 0.75 https://www.medxy.ai/news/vi/fistulotomy-with-primary-sphincteroplasty-for-complex-anal-fistulas-balancing-cure-with-continence-preservation-2 2026-07-07T09:11:27.000Z daily 0.75 https://www.medxy.ai/news/ja/fistulotomy-with-primary-sphincteroplasty-for-complex-anal-fistulas-balancing-cure-with-continence-preservation-3 2026-07-07T09:11:29.000Z daily 0.75 https://www.medxy.ai/news/zh/fistulotomy-with-primary-sphincteroplasty-for-complex-anal-fistulas-balancing-cure-with-continence-preservation-4 2026-07-07T09:11:32.000Z daily 0.75 https://www.medxy.ai/news/predictive-role-of-the-modified-frailty-index-in-short-term-complications-after-total-thyroidectomy 2026-07-05T16:43:37.000Z daily 0.75 https://www.medxy.ai/news/vi/predictive-role-of-the-modified-frailty-index-in-short-term-complications-after-total-thyroidectomy-2 2026-07-07T09:11:12.000Z daily 0.75 https://www.medxy.ai/news/ja/predictive-role-of-the-modified-frailty-index-in-short-term-complications-after-total-thyroidectomy-3 2026-07-07T09:11:15.000Z daily 0.75 https://www.medxy.ai/news/zh/predictive-role-of-the-modified-frailty-index-in-short-term-complications-after-total-thyroidectomy-4 2026-07-07T09:11:19.000Z daily 0.75 https://www.medxy.ai/news/elevated-blood-manganese-linked-to-increased-risk-of-head-and-neck-squamous-cell-carcinomas-insights-from-mendelian-randomization 2026-07-05T16:41:03.000Z daily 0.75 https://www.medxy.ai/news/vi/elevated-blood-manganese-linked-to-increased-risk-of-head-and-neck-squamous-cell-carcinomas-insights-from-mendelian-randomization-3 2026-07-07T09:11:03.000Z daily 0.75 https://www.medxy.ai/news/ja/elevated-blood-manganese-linked-to-increased-risk-of-head-and-neck-squamous-cell-carcinomas-insights-from-mendelian-randomization-2 2026-07-07T09:11:00.000Z daily 0.75 https://www.medxy.ai/news/zh/%E8%A1%80%E9%94%B0%E5%8D%87%E9%AB%98%E6%88%96%E5%A2%9E%E5%8A%A0%E5%A4%B4%E9%A2%88%E9%83%A8%E9%B3%9E%E7%8A%B6%E7%BB%86%E8%83%9E%E7%99%8C%E9%A3%8E%E9%99%A9%EF%BC%9A%E5%AD%9F%E5%BE%B7%E5%B0%94%E9%9A%8F 2026-07-05T16:43:57.000Z daily 0.75 https://www.medxy.ai/news/disparities-in-access-to-intravitreal-anti-vegf-therapies-among-medicare-advantage-versus-fee-for-service-beneficiaries 2026-07-05T16:46:50.000Z daily 0.75 https://www.medxy.ai/news/enhancing-glaucoma-diagnosis-in-myopia-validating-oct-based-prespecified-rules-for-optic-neuropathy-detection 2026-07-07T09:10:11.000Z daily 0.75 https://www.medxy.ai/news/vi/enhancing-glaucoma-diagnosis-in-myopia-validating-oct-based-prespecified-rules-for-optic-neuropathy-detection-2 2026-07-07T09:10:29.000Z daily 0.75 https://www.medxy.ai/news/ja/enhancing-glaucoma-diagnosis-in-myopia-validating-oct-based-prespecified-rules-for-optic-neuropathy-detection-3 2026-07-07T09:10:36.000Z daily 0.75 https://www.medxy.ai/news/zh/enhancing-glaucoma-diagnosis-in-myopia-validating-oct-based-prespecified-rules-for-optic-neuropathy-detection-4 2026-07-07T09:10:43.000Z daily 0.75 https://www.medxy.ai/news/corneal-nerve-alterations-and-sensory-deficits-in-unilateral-noninfectious-anterior-uveitis-a-cross-sectional-study 2026-07-05T16:52:02.000Z daily 0.75 https://www.medxy.ai/news/vi/corneal-nerve-alterations-and-sensory-deficits-in-unilateral-noninfectious-anterior-uveitis-a-cross-sectional-study-2 2026-07-07T09:09:57.000Z daily 0.75 https://www.medxy.ai/news/comparing-early-restrictive-and-liberal-fluid-strategies-in-sepsis-induced-hypotension-long-term-effects-on-patient-centered-outcomes 2026-07-05T19:00:49.000Z daily 0.75 https://www.medxy.ai/news/vi/comparing-early-restrictive-and-liberal-fluid-strategies-in-sepsis-induced-hypotension-long-term-effects-on-patient-centered-outcomes-4 2026-07-07T09:09:46.000Z daily 0.75 https://www.medxy.ai/news/ja/comparing-early-restrictive-and-liberal-fluid-strategies-in-sepsis-induced-hypotension-long-term-effects-on-patient-centered-outcomes-3 2026-07-07T09:09:38.000Z daily 0.75 https://www.medxy.ai/news/zh/comparing-early-restrictive-and-liberal-fluid-strategies-in-sepsis-induced-hypotension-long-term-effects-on-patient-centered-outcomes-2 2026-07-07T09:09:29.000Z daily 0.75 https://www.medxy.ai/news/impact-of-short-term-high-altitude-exposure-on-right-ventricular-load-and-oxygen-delivery-in-pulmonary-vascular-disease-patients 2026-07-05T20:52:09.000Z daily 0.75 https://www.medxy.ai/news/vi/impact-of-short-term-high-altitude-exposure-on-right-ventricular-load-and-oxygen-delivery-in-pulmonary-vascular-disease-patients-4 2026-07-07T09:09:13.000Z daily 0.75 https://www.medxy.ai/news/ja/impact-of-short-term-high-altitude-exposure-on-right-ventricular-load-and-oxygen-delivery-in-pulmonary-vascular-disease-patients-3 2026-07-07T09:09:03.000Z daily 0.75 https://www.medxy.ai/news/zh/impact-of-short-term-high-altitude-exposure-on-right-ventricular-load-and-oxygen-delivery-in-pulmonary-vascular-disease-patients-2 2026-07-07T09:08:59.000Z daily 0.75 https://www.medxy.ai/news/engineering-single-chain-variable-fragments-to-identify-pathogenic-antibodies-in-heparin-induced-thrombocytopenia 2026-07-06T08:42:48.000Z daily 0.75 https://www.medxy.ai/news/vi/engineering-single-chain-variable-fragments-to-identify-pathogenic-antibodies-in-heparin-induced-thrombocytopenia-2 2026-07-07T09:08:42.000Z daily 0.75 https://www.medxy.ai/news/ja/engineering-single-chain-variable-fragments-to-identify-pathogenic-antibodies-in-heparin-induced-thrombocytopenia-3 2026-07-07T09:08:45.000Z daily 0.75 https://www.medxy.ai/news/linperlisib-potentiates-muc1-tn-car-t-cell-therapy-by-suppressing-the-egr1-dusp2-axis-to-combat-t-cell-acute-lymphoblastic-leukemia 2026-07-06T08:53:57.000Z daily 0.75 https://www.medxy.ai/news/vi/linperlisib-potentiates-muc1-tn-car-t-cell-therapy-by-suppressing-the-egr1-dusp2-axis-to-combat-t-cell-acute-lymphoblastic-leukemia-2 2026-07-07T13:45:14.000Z daily 0.75 https://www.medxy.ai/news/ja/linperlisib-potentiates-muc1-tn-car-t-cell-therapy-by-suppressing-the-egr1-dusp2-axis-to-combat-t-cell-acute-lymphoblastic-leukemia-3 2026-07-07T09:08:29.000Z daily 0.75 https://www.medxy.ai/news/zh/linperlisib-potentiates-muc1-tn-car-t-cell-therapy-by-suppressing-the-egr1-dusp2-axis-to-combat-t-cell-acute-lymphoblastic-leukemia-4 2026-07-07T09:08:33.000Z daily 0.75 https://www.medxy.ai/news/recurrent-venous-thromboembolism-after-isolated-distal-dvt-insights-from-the-ridts-trial 2026-07-07T13:11:51.000Z daily 0.75 https://www.medxy.ai/news/vi/recurrent-venous-thromboembolism-after-isolated-distal-dvt-insights-from-the-ridts-trial-2 2026-07-09T08:59:32.000Z daily 0.75 https://www.medxy.ai/news/ja/recurrent-venous-thromboembolism-after-isolated-distal-dvt-insights-from-the-ridts-trial-3 2026-07-09T08:59:27.000Z daily 0.75 https://www.medxy.ai/news/zh/recurrent-venous-thromboembolism-after-isolated-distal-dvt-insights-from-the-ridts-trial-4 2026-07-07T13:43:42.000Z daily 0.75 https://www.medxy.ai/news/a-comprehensive-prognostic-model-for-predicting-leukemia-free-survival-following-allogeneic-hematopoietic-cell-transplantation-in-acute-leukemia 2026-07-07T13:18:37.000Z daily 0.75 https://www.medxy.ai/news/vi/a-comprehensive-prognostic-model-for-predicting-leukemia-free-survival-following-allogeneic-hematopoietic-cell-transplantation-in-acute-leukemia-2 2026-07-09T08:59:19.000Z daily 0.75 https://www.medxy.ai/news/ja/a-comprehensive-prognostic-model-for-predicting-leukemia-free-survival-following-allogeneic-hematopoietic-cell-transplantation-in-acute-leukemia-3 2026-07-09T08:59:13.000Z daily 0.75 https://www.medxy.ai/news/zh/a-comprehensive-prognostic-model-for-predicting-leukemia-free-survival-following-allogeneic-hematopoietic-cell-transplantation-in-acute-leukemia-4 2026-07-07T13:43:23.000Z daily 0.75 https://www.medxy.ai/news/harnessing-real-world-evidence-to-optimize-glp-1-based-therapies-insights-from-a-niddk-workshop 2026-07-07T13:20:35.000Z daily 0.75 https://www.medxy.ai/news/sibling-controlled-evidence-reassures-safety-of-prenatal-acetaminophen-use-regarding-autism-and-adhd-risks 2026-07-07T13:25:02.000Z daily 0.75 https://www.medxy.ai/news/vi/sibling-controlled-evidence-reassures-safety-of-prenatal-acetaminophen-use-regarding-autism-and-adhd-risks-2 2026-07-09T08:59:02.000Z daily 0.75 https://www.medxy.ai/news/ja/sibling-controlled-evidence-reassures-safety-of-prenatal-acetaminophen-use-regarding-autism-and-adhd-risks-3 2026-07-09T08:58:53.000Z daily 0.75 https://www.medxy.ai/news/zh/sibling-controlled-evidence-reassures-safety-of-prenatal-acetaminophen-use-regarding-autism-and-adhd-risks-4 2026-07-09T08:58:45.000Z daily 0.75 https://www.medxy.ai/news/strengthening-social-support-networks-to-reduce-turnover-in-primary-care-teams 2026-07-07T13:37:28.000Z daily 0.75 https://www.medxy.ai/news/vi/social-support-networks-to-reduce-turnover-in-primary-care 2026-07-09T08:58:33.000Z daily 0.75 https://www.medxy.ai/news/ja/social-support-networks-to-reduce-turnover-in-primary-care-2 2026-07-09T08:58:21.000Z daily 0.75 https://www.medxy.ai/news/zh/social-support-networks-to-reduce-turnover-in-primary-care-3 2026-07-09T08:58:13.000Z daily 0.75 https://www.medxy.ai/news/variation-in-pediatric-critical-illness-experience-across-emergency-departments-implications-for-care-and-transport 2026-07-07T13:46:38.000Z daily 0.75 https://www.medxy.ai/news/vi/variation-in-pediatric-critical-illness-experience 2026-07-09T08:58:03.000Z daily 0.75 https://www.medxy.ai/news/ja/variation-in-pediatric-critical-illness-experience-2 2026-07-09T08:57:56.000Z daily 0.75 https://www.medxy.ai/news/identifying-cardiovascular-subphenotypes-in-sepsis-toward-personalized-hemodynamic-management 2026-07-07T13:49:16.000Z daily 0.75 https://www.medxy.ai/news/vi/identifying-cardiovascular-subphenotypes-in-sepsis 2026-07-09T08:57:40.000Z daily 0.75 https://www.medxy.ai/news/harnessing-machine-learning-for-prognostic-precision-in-secondary-hemophagocytic-lymphohistiocytosis 2026-07-07T13:54:29.000Z daily 0.75 https://www.medxy.ai/news/vi/harnessing-machine-learning-for-prognostic 2026-07-09T08:57:26.000Z daily 0.75 https://www.medxy.ai/news/ja/harnessing-machine-learning-for-prognostic-2 2026-07-09T08:57:32.000Z daily 0.75 https://www.medxy.ai/news/zh/harnessing-machine-learning-for-prognostic-3 2026-07-07T20:50:48.000Z daily 0.75 https://www.medxy.ai/news/intermittent-theta-burst-stimulation-of-the-dorsomedial-prefrontal-cortex-enhances-expectancy-driven-placebo-mood-effects-in-depression-evidence-from-a-randomized-clinical-trial 2026-07-09T08:56:57.000Z daily 0.75 https://www.medxy.ai/news/vi/intermittent-theta-burst-stimulation-of-the-dorsomedial-prefrontal-cortex-enhances-expectancy-driven-placebo-mood-effects-in-depression 2026-07-09T08:56:51.000Z daily 0.75 https://www.medxy.ai/news/ja/intermittent-theta-burst-stimulation-of-the-dorsomedial-prefrontal-cortex-enhances-expectancy-driven-placebo-mood-effects-in-depression-2 2026-07-09T08:56:45.000Z daily 0.75 https://www.medxy.ai/news/zh/intermittent-theta-burst-stimulation-of-the-dorsomedial-prefrontal-cortex-enhances-expectancy-driven-placebo-mood-effects-in-depression-3 2026-07-09T08:56:37.000Z daily 0.75 https://www.medxy.ai/news/sept9-for-early-detection-of-hepatocellular-carcinoma-in-cirrhotic-patients 2026-07-09T08:56:29.000Z daily 0.75 https://www.medxy.ai/news/vi/sept9-hepatocellular-carcinoma-in-cirrhotic 2026-07-09T08:56:19.000Z daily 0.75 https://www.medxy.ai/news/zh/sept9-for-hepatocellular-carcinoma-in-cirrhotic-patients 2026-07-09T08:56:04.000Z daily 0.75 https://www.medxy.ai/news/adolescent-cardiorespiratory-fitness 2026-07-07T21:15:29.000Z daily 0.75 https://www.medxy.ai/news/sirolimus-eluting-balloons-in-coronary-in-stent-restenosis 2026-07-07T21:18:29.000Z daily 0.75 https://www.medxy.ai/news/obicetrapibs-impact-on-lipoproteina-in-high-cardiovascular-risk-patients-a-comprehensive-pooled-analysis 2026-07-07T21:19:40.000Z daily 0.75 https://www.medxy.ai/news/human-versus-analogue-insulin-for-youth-with-type-1-diabetes 2026-07-09T08:55:39.000Z daily 0.75 https://www.medxy.ai/news/vi/insulin-for-youth-with-type-1-diabetes 2026-07-09T08:55:28.000Z daily 0.75 https://www.medxy.ai/news/ja/insulin-for-youth-with-td1m 2026-07-09T08:55:18.000Z daily 0.75 https://www.medxy.ai/news/precision-medicine-enhances-managementin-young-onset-diabetes 2026-07-08T12:50:18.000Z daily 0.75 https://www.medxy.ai/news/vi/precision-medicine-for-young-onset-diabetes 2026-07-09T08:55:02.000Z daily 0.75 https://www.medxy.ai/news/evolving-paradigms-in-diagnosing-cushings-disease 2026-07-08T13:18:19.000Z daily 0.75 https://www.medxy.ai/news/vi/paradigms-in-diagnosing-cushings-disease 2026-07-09T08:54:54.000Z daily 0.75 https://www.medxy.ai/news/gip-in-regulating-postprandial-splanchnic-blood-flow 2026-07-08T13:26:50.000Z daily 0.75 https://www.medxy.ai/news/vi/gip-regulating-postprandial-splanchnic-blood-flow 2026-07-09T08:54:43.000Z daily 0.75 https://www.medxy.ai/news/ja/gip-regulating-postprandial-splanchnic-blood-flow-t2dm 2026-07-09T08:54:36.000Z daily 0.75 https://www.medxy.ai/news/zh/gip-regulating-splanchnic-blood-flow-t2dm 2026-07-08T13:27:29.000Z daily 0.75 https://www.medxy.ai/news/thyroxine-therapy-in-adult-resistance-to-thyroid-hormone-alpha-rth%CE%B1-clinical-efficacy-safety-and-metabolic-insights 2026-07-08T13:26:19.000Z daily 0.75 https://www.medxy.ai/news/vi/dieu-tri-thyroxine-o-nguoi-truong-thanh-khang-hormon-tuyen-giap-alpha-rth%CE%B1-hieu-qua-lam-sang-tinh-an-toan-va-nhung-goi-y-chuyen-hoa 2026-07-09T08:54:28.000Z daily 0.75 https://www.medxy.ai/news/ja/%E6%88%90%E4%BA%BA%E3%81%AE%E7%94%B2%E7%8A%B6%E8%85%BA%E3%83%9B%E3%83%AB%E3%83%A2%E3%83%B3%CE%B1%E6%8A%B5%E6%8A%97%E7%97%87%EF%BC%88resistance-to-thyroid-hormone-alpha-rth%CE%B1%EF%BC%89%E3%81%AB 2026-07-09T08:54:21.000Z daily 0.75 https://www.medxy.ai/news/zh/%E6%88%90%E4%BA%BA%E7%94%B2%E7%8A%B6%E8%85%BA%E6%BF%80%E7%B4%A0%CE%B1%E5%9E%8B%E6%8A%B5%E6%8A%97%EF%BC%88rth%CE%B1%EF%BC%89%E7%9A%84%E5%B7%A6%E7%94%B2%E7%8A%B6%E8%85%BA%E7%B4%A0%E6%B2%BB%E7%96%97 2026-07-09T08:54:15.000Z daily 0.75 https://www.medxy.ai/news/levacetylleucine-shows-promising-safety-and-efficacy-in-treating-ataxia-telangiectasia-phase-3-trial-findings 2026-07-08T13:33:10.000Z daily 0.75 https://www.medxy.ai/news/vi/levacetylleucine-cho-thay-tinh-an-toan-va-hieu-qua-day-hua-hen-trong-dieu-tri-ataxia-telangiectasia-ket-qua-thu-nghiem-giai-doan-3 2026-07-09T08:54:09.000Z daily 0.75 https://www.medxy.ai/news/ja/levacetylleucine%E3%80%81a-t%E3%81%AB%E6%9C%89%E6%9C%9B%E3%81%AA%E5%AE%89%E5%85%A8%E6%80%A7%E3%83%BB%E6%9C%89%E5%8A%B9%E6%80%A7%E3%80%80%E7%AC%AC3%E7%9B%B8%E8%A9%A6%E9%A8%93%E3%81%A7%E7%A5%9E%E7%B5%8C 2026-07-09T08:54:02.000Z daily 0.75 https://www.medxy.ai/news/zh/levacetylleucine%E5%9C%A8%E5%85%B1%E6%B5%8E%E5%A4%B1%E8%B0%83-%E6%AF%9B%E7%BB%86%E8%A1%80%E7%AE%A1%E6%89%A9%E5%BC%A0%E7%97%87%E6%B2%BB%E7%96%97%E4%B8%AD%E6%98%BE%E7%A4%BA%E5%87%BA%E8%89%AF%E5%A5%BD 2026-07-09T08:53:54.000Z daily 0.75 https://www.medxy.ai/news/decoding-tofersens-cns-penetrance-and-efficacy-in-sod1-als-through-autopsy-tissue-analysis 2026-07-08T13:36:48.000Z daily 0.75 https://www.medxy.ai/news/lrp4-antibody-associated-myasthenia-gravis 2026-07-08T13:43:32.000Z daily 0.75 https://www.medxy.ai/news/vi/lrp4-associated-myasthenia-gravis 2026-07-09T08:53:39.000Z daily 0.75 https://www.medxy.ai/news/ja/lrp4-associated-myasthenia-gravis-2 2026-07-09T08:53:34.000Z daily 0.75 https://www.medxy.ai/news/zh/lrp4-associated-myasthenia-gravis-in-german 2026-07-08T13:45:33.000Z daily 0.75 https://www.medxy.ai/news/beyond-aspects-defining-the-therapeutic-limit-of-endovascular-thrombectomy-in-large-core-ischemic-stroke 2026-07-08T13:44:20.000Z daily 0.75 https://www.medxy.ai/news/redefining-patient-selection-for-endovascular-thrombectomy-in-large-core-ischemic-stroke 2026-07-08T13:46:40.000Z daily 0.75 https://www.medxy.ai/news/vi/endovascular-thrombectomy-in-ischemic-stroke 2026-07-09T08:53:22.000Z daily 0.75 https://www.medxy.ai/news/from-gut-feeling-to-brain-mapping-decoding-defecation-urgency-in-ibs 2026-07-08T13:49:00.000Z daily 0.75 https://www.medxy.ai/news/vi/from-gut-feeling-to-brain-mapping 2026-07-09T08:53:04.000Z daily 0.75 https://www.medxy.ai/news/ja/gut-feeling-to-brain-mapping 2026-07-09T08:52:57.000Z daily 0.75 https://www.medxy.ai/news/zh/gut-feeling-to-brain-mapping-in-ibs 2026-07-08T13:53:57.000Z daily 0.75 https://www.medxy.ai/news/targeting-smpd1-driven-sphingolipid-metabolism-to-disrupt-kras-signaling-in-pancreatic-ductal-adenocarcinoma 2026-07-08T13:51:48.000Z daily 0.75 https://www.medxy.ai/news/vi/smpd1-driven-sphingolipid-metabolism-to-disrupt-kras-signaling 2026-07-09T08:52:44.000Z daily 0.75 https://www.medxy.ai/news/ja/smpd1-in-pancreatic-ductal-adenocarcinoma 2026-07-09T08:52:37.000Z daily 0.75 https://www.medxy.ai/news/zh/smpd1-driven-sphingolipid-metabolism-in-pancreatic-ductal-adenocarcinoma 2026-07-08T13:54:59.000Z daily 0.75 https://www.medxy.ai/news/klf9-nr4a1-p38-mapk-axis-in-obstructive-sleep-apnea 2026-07-08T13:59:23.000Z daily 0.75 https://www.medxy.ai/news/vi/klf9-nr4a1-p38-mapk-in-obstructive-sleep-apnea 2026-07-09T08:52:22.000Z daily 0.75 https://www.medxy.ai/news/ja/klf9-nr4a1-p38-mapk-axis-in-osa 2026-07-09T08:52:12.000Z daily 0.75 https://www.medxy.ai/news/zh/klf9-nr4a1-p38-mapk-in-osa 2026-07-09T08:52:00.000Z daily 0.75 https://www.medxy.ai/news/evaluation-of-postpartum-glucose-tolerance-test-results-based-on-criteria-and-timing 2026-07-09T08:51:51.000Z daily 0.75 https://www.medxy.ai/news/vi/postpartum-glucose-tolerance-test-results 2026-07-09T08:51:45.000Z daily 0.75 https://www.medxy.ai/news/early-home-removal-of-urinary-catheters-after-urogynecologic-surgery 2026-07-08T14:05:22.000Z daily 0.75 https://www.medxy.ai/news/vi/early-removal-of-urinary-catheters-after-urogynecologic-surgery 2026-07-09T08:51:28.000Z daily 0.75 https://www.medxy.ai/news/ja/early-home-removal-of-urinary-catheters-after-urogynecologic-surgery-rct 2026-07-09T08:51:20.000Z daily 0.75 https://www.medxy.ai/news/zh/removal-of-urinary-catheters-after-urogynecologic-surgery 2026-07-09T08:51:09.000Z daily 0.75 https://www.medxy.ai/news/labour-progression-differences-between-ivf-icsi-and-spontaneous-pregnancies-following-induction-insights-from-a-matched-cohort-study 2026-07-08T14:05:06.000Z daily 0.75 https://www.medxy.ai/news/adjunctive-sglt2-inhibitors-with-progestins-reduce-endometrial-cancer-risk 2026-07-08T14:37:20.000Z daily 0.75 https://www.medxy.ai/news/vi/sglt2-inhibitors-with-progestins-reduce-endometrial-cancer-risk 2026-07-09T08:50:56.000Z daily 0.75 https://www.medxy.ai/news/ja/sglt2-inhibitors-reduce-endometrial-cancer-risk 2026-07-08T14:37:39.000Z daily 0.75 https://www.medxy.ai/news/zh/sglt2-inhibitors-reduce-endometrial-cancer 2026-07-09T08:50:44.000Z daily 0.75 https://www.medxy.ai/news/expanding-the-horizon-of-simultaneous-liver-kidney-transplantation-leveraging-dcd-donors-with-machine-perfusion-technologies 2026-07-08T14:36:21.000Z daily 0.75 https://www.medxy.ai/news/vi/expanding-the-horizon-of-simultaneous-liver-kidney-transplantation 2026-07-09T08:50:25.000Z daily 0.75 https://www.medxy.ai/news/ja/horizon-of-simultaneous-liver-kidney-transplantation 2026-07-09T08:50:14.000Z daily 0.75 https://www.medxy.ai/news/zh/simultaneous-liver-kidney-transplantation 2026-07-08T19:27:43.000Z daily 0.75 https://www.medxy.ai/news/outcomes-of-sacrospinous-hysteropexy-with-mesh-versus-vaginal-hysterectomy-for-uterovaginal-prolapse 2026-07-08T20:44:39.000Z daily 0.75 https://www.medxy.ai/news/vi/outcomes-of-sacrospinous-hysteropexy-with-mesh-versus-vaginal-hysterectomy-for-uterovaginal-prolapse-2 2026-07-09T08:49:39.000Z daily 0.75 https://www.medxy.ai/news/ja/sacrospinous-hysteropexy-with-mesh-versus-vaginal-hysterectomy-for-uterovaginal-prolapse 2026-07-09T08:49:29.000Z daily 0.75 https://www.medxy.ai/news/zh/sacrospinous-hysteropexy-with-mesh-or-uterovaginal-prolapse 2026-07-09T08:49:20.000Z daily 0.75 https://www.medxy.ai/news/impact-of-modified-frailty-index-on-liver-transplant-outcomes-insights-from-a-multicenter-cohort-study 2026-07-08T20:21:56.000Z daily 0.75 https://www.medxy.ai/news/vi/impact-of-modified-frailty-index-on-liver-transplant-outcomes 2026-07-09T08:49:06.000Z daily 0.75 https://www.medxy.ai/news/ja/modified-frailty-index-on-liver-transplant-outcomes 2026-07-09T08:48:58.000Z daily 0.75 https://www.medxy.ai/news/zh/modified-frailty-index-on-liver-transplant 2026-07-08T20:44:01.000Z daily 0.75 https://www.medxy.ai/news/vocal-fold-opening-position-on-bowing-measures-in-age-related-vocal-atrophy 2026-07-08T20:46:16.000Z daily 0.75 https://www.medxy.ai/news/vi/vocal-fold-opening-position-on-bowing-in-age-related-vocal-atrophy 2026-07-09T08:48:42.000Z daily 0.75 https://www.medxy.ai/news/ja/vocal-fold-opening-position-in-age-related-vocal-atrophy 2026-07-09T08:48:30.000Z daily 0.75 https://www.medxy.ai/news/zh/vocal-fold-opening-position-in-vocal-atrophy 2026-07-08T20:48:19.000Z daily 0.75 https://www.medxy.ai/news/antireflux-diet-versus-medication-a-comparative-analysis-in-laryngopharyngeal-reflux-disease-management 2026-07-08T20:48:50.000Z daily 0.75 https://www.medxy.ai/news/vi/antireflux-diet-versus-medication 2026-07-09T08:48:21.000Z daily 0.75 https://www.medxy.ai/news/ja/antireflux-diet-versus-medication-2 2026-07-09T08:48:12.000Z daily 0.75 https://www.medxy.ai/news/zh/antireflux-diet-versus-medication-3 2026-07-09T07:25:51.000Z daily 0.75 https://www.medxy.ai/news/evaluating-the-clinical-utility-of-10-2-visual-field-testing-in-early-glaucoma-progression-detection 2026-07-09T07:25:50.000Z daily 0.75 https://www.medxy.ai/news/vi/visual-field-testing-in-early-glaucoma-progression-detection 2026-07-09T08:48:00.000Z daily 0.75 https://www.medxy.ai/news/ja/visual-field-testing-in-early-glaucoma 2026-07-09T08:47:54.000Z daily 0.75 https://www.medxy.ai/news/zh/visual-field-testing-in-early-glaucoma-progression 2026-07-09T08:45:11.000Z daily 0.75 https://www.medxy.ai/news/blood-pressure-assessment-in-ophthalmology-clinics-for-patients-with-diabetes 2026-07-09T08:47:45.000Z daily 0.75 https://www.medxy.ai/news/evaluating-the-isold-score-for-accurate-diagnosis-of-vitreoretinal-lymphoma-in-clinical-practice 2026-07-09T08:47:13.000Z daily 0.75 https://www.medxy.ai/news/vi/isold-score-for-vitreoretinal-lymphoma 2026-07-09T09:01:21.000Z daily 0.75 https://www.medxy.ai/news/ja/isold-score-in-vitreoretinal-lymphoma 2026-07-09T09:01:28.000Z daily 0.75 https://www.medxy.ai/news/zh/isold-score-and-vitreoretinal-lymphoma 2026-07-09T09:01:36.000Z daily 0.75 https://www.medxy.ai/news/enhancing-treatment-evaluation-in-fibrotic-interstitial-lung-disease-a-joint-model-of-lung-function-decline-and-mortality 2026-07-09T09:01:57.000Z daily 0.75 https://www.medxy.ai/news/vi/enhancing-treatment-evaluation-in-fibrotic-interstitial-lung-disease 2026-07-09T09:07:48.000Z daily 0.75 https://www.medxy.ai/news/ja/enhancing-treatment-evaluation-in-fid 2026-07-09T09:08:06.000Z daily 0.75 https://www.medxy.ai/news/zh/lung-function-decline-and-mortality-in-fibrotic-interstitial-lung-disease 2026-07-09T09:08:28.000Z daily 0.75 https://www.medxy.ai/news/radiation-exposure-in-bronchoscopy-conventional-fluoroscopy-versus-robotic-techniques 2026-07-09T09:07:02.000Z daily 0.75 https://www.medxy.ai/news/vi/radiation-exposure-in-bronchoscopy 2026-07-09T10:01:42.000Z daily 0.75 https://www.medxy.ai/news/ja/radiation-exposure-in-bronchoscopy-conventional-fluoroscopy-vs-robotic-techniques 2026-07-09T10:02:13.000Z daily 0.75 https://www.medxy.ai/news/zh/radiation-exposure-in-bronchoscopy-fluoroscopy-versus-robotic-techniques 2026-07-09T10:02:27.000Z daily 0.75 https://www.medxy.ai/news/unveiling-non-pf4-heparin-binding-platelet-activating-antibodies-in-heparin-induced-thrombocytopenia-implications-for-diagnosis-and-pathogenesis 2026-07-09T10:03:05.000Z daily 0.75 https://www.medxy.ai/news/vi/unveiling-non-pf4-heparin-binding-platelet-activating-antibodies-in-heparin-induced-thrombocytopenia 2026-07-09T11:43:27.000Z daily 0.75 https://www.medxy.ai/news/ja/non-pf4-heparin-binding-platelet-activating-antibodies-in-heparin-induced-thrombocytopenia 2026-07-09T11:43:22.000Z daily 0.75 https://www.medxy.ai/news/decoding-resistance-to-tagraxofusp-in-blastic-plasmacytoid-dendritic-cell-neoplasm-the-role-of-txnrd1-and-tet2-mutations 2026-07-09T10:17:35.000Z daily 0.75 https://www.medxy.ai/news/vi/decoding-resistance-to-tagraxofusp-in-blastic-plasmacytoid-dendritic-cell-neoplasm 2026-07-09T11:43:49.000Z daily 0.75 https://www.medxy.ai/news/ja/resistance-to-tagraxofusp-in-blastic-plasmacytoid-dendritic-cell-neoplasm 2026-07-09T13:42:31.000Z daily 0.75 https://www.medxy.ai/news/zh/tagraxofusp-in-blastic-plasmacytoid-dendritic-cell-neoplasm 2026-07-09T11:44:13.000Z daily 0.75 https://www.medxy.ai/news/long-term-outcomes-of-oral-decitabine-cedazuridine-plus-venetoclax-in-older-or-unfit-patients-with-newly-diagnosed-acute-myeloid-leukemia 2026-07-09T13:42:19.000Z daily 0.75 https://www.medxy.ai/news/vi/oral-decitabine-cedazuridine-plus-venetoclax-in-patients-with-newly-diagnosed-acute-myeloid-leukemia 2026-07-09T13:42:11.000Z daily 0.75 https://www.medxy.ai/news/ja/decitabine-cedazuridine-plus-venetoclax-for-acute-myeloid-leukemia 2026-07-09T13:42:04.000Z daily 0.75 https://www.medxy.ai/news/chime-a-novel-hla-eplet-model-predicting-non-relapse-mortality-in-haploidentical-hematopoietic-cell-transplantation 2026-07-09T11:44:30.000Z daily 0.75 https://www.medxy.ai/news/vi/non-relapse-mortality-in-haploidentical-hematopoietic-cell-transplantation 2026-07-09T13:41:57.000Z daily 0.75 https://www.medxy.ai/news/impact-of-chronic-mild-sleep-restriction-on-body-weight-and-composition-insights-from-pooled-randomized-trials 2026-07-09T12:26:33.000Z daily 0.75 https://www.medxy.ai/news/vi/impact-of-chronic-mild-sleep-restriction-on-body-weight-and-composition 2026-07-09T13:41:41.000Z daily 0.75 https://www.medxy.ai/news/ja/chronic-mild-sleep-restriction-on-body-weight-and-composition 2026-07-09T13:41:37.000Z daily 0.75 https://www.medxy.ai/news/zh/chronic-sleep-restriction-on-body-weight-and-composition 2026-07-09T13:17:55.000Z daily 0.75 https://www.medxy.ai/news/point-of-care-multiplex-pcr-testing-in-nursing-homes-impact-on-respiratory-outbreak-management-and-emergency-transfers 2026-07-09T13:41:17.000Z daily 0.75 https://www.medxy.ai/news/vi/point-of-care-multiplex-pcr-testing-in-nursing-homes-impact-on-respiratory-outbreak 2026-07-09T13:41:01.000Z daily 0.75 https://www.medxy.ai/news/ja/point-of-care-multiplex-pcr-testing-on-respiratory-outbreak 2026-07-09T13:40:34.000Z daily 0.75 https://www.medxy.ai/news/zh/poct-testing-on-respiratory-outbreak 2026-07-09T13:40:13.000Z daily 0.75 https://www.medxy.ai/news/prolonged-emergency-department-stay-linked-to-increased-30-day-mortality 2026-07-09T13:38:21.000Z daily 0.75 https://www.medxy.ai/news/vi/prolonged-emergency-department-stay-linked-to-increased-mortality 2026-07-09T13:39:52.000Z daily 0.75 https://www.medxy.ai/news/ja/prolonged-emergency-department-increased-mortality 2026-07-09T13:39:41.000Z daily 0.75 https://www.medxy.ai/news/zh/prolonged-emergency-increased-mortality 2026-07-09T13:44:11.000Z daily 0.75 https://www.medxy.ai/news/ai-driven-real-time-monitoring-of-inspiratory-effort-and-patient-ventilator-synchrony 2026-07-09T14:01:27.000Z daily 0.75 https://www.medxy.ai/news/vi/ai-driven-real-time-monitoring-of-inspiratory-effort 2026-07-09T14:01:40.000Z daily 0.75 https://www.medxy.ai/news/ja/ai-driven-inspiratory-effort-and-patient-ventilator-synchrony 2026-07-09T14:01:51.000Z daily 0.75 https://www.medxy.ai/news/zh/ai-driven-real-time-monitoring-of-inspiratory-effort-and-ventilator-synchrony 2026-07-09T14:02:14.000Z daily 0.75 https://www.medxy.ai/news/optimizing-intraoperative-blood-pressure-in-hypertensive-high-risk-patients 2026-07-09T14:02:28.000Z daily 0.75 https://www.medxy.ai/news/vi/intraoperative-blood-pressure-in-hypertensive-high-risk-patients 2026-07-09T14:02:33.000Z daily 0.75 https://www.medxy.ai/news/ja/intraoperative-blood-pressure-in-hypertensive-patients 2026-07-09T14:02:42.000Z daily 0.75 https://www.medxy.ai/news/zh/intraoperative-blood-pressure-in-hypertensive 2026-07-09T16:32:40.000Z daily 0.75 https://www.medxy.ai/news/2026-updated-multidisciplinary-guidance-for-primary-localized-chordoma 2026-07-09T21:57:31.000Z daily 0.75 https://www.medxy.ai/news/zh/multidisciplinary-guidance-for-primary-localized-chordoma 2026-07-09T21:57:40.000Z daily 0.75 https://www.medxy.ai/news/vi/guidance-for-primary-localized-chordoma 2026-07-09T22:00:04.000Z daily 0.75 https://www.medxy.ai/news/ja/guidance-in-primary-localized-chordoma 2026-07-09T21:59:58.000Z daily 0.75 https://www.medxy.ai/news/unveiling-the-natural-history-of-asymptomatic-mild-hypertrophic-cardiomyopathy-insights-from-the-share-registry 2026-07-09T21:57:09.000Z daily 0.75 https://www.medxy.ai/news/vi/the-natural-history-of-asymptomatic-mild-hypertrophic-cardiomyopathy 2026-07-10T12:24:59.000Z daily 0.75 https://www.medxy.ai/news/risk-weighted-apob 2026-07-10T12:24:10.000Z daily 0.75 https://www.medxy.ai/news/vi/risk-weighted-apob-coronary-heart-disease 2026-07-10T12:24:54.000Z daily 0.75 https://www.medxy.ai/news/clinical-diagnosis-of-calcium-release-deficiency-syndrome-in-a-family-with-sudden-cardiac-death 2026-07-10T12:25:26.000Z daily 0.75 https://www.medxy.ai/news/longitudinal-changes-in-cortisol-secretion-and-cardiometabolic-outcomes-in-benign-adrenal-incidentalomas-insights-from-a-large-retrospective-cohort 2026-07-10T12:26:47.000Z daily 0.75 https://www.medxy.ai/news/vi/longitudinal-changes-in-cortisol-secretion-and-cardiometabolic-outcomes-in-benign-adrenal-incidentalomas 2026-07-10T13:38:20.000Z daily 0.75 https://www.medxy.ai/news/ja/cortisol-secretion-and-cardiometabolic-outcomes-in-benign-adrenal-incidentalomas 2026-07-10T13:38:10.000Z daily 0.75 https://www.medxy.ai/news/early-detection-of-%CE%B2-cell-preservation-in-new-onset-type-1-diabetes 2026-07-10T13:35:29.000Z daily 0.75 https://www.medxy.ai/news/vi/early-detection-of-%CE%B2-cell-preservation-in-new-onset-td1m 2026-07-10T13:37:57.000Z daily 0.75 https://www.medxy.ai/news/ja/early-detection-of-%CE%B2cell-preservation-in-new-onset-td1m 2026-07-10T13:37:50.000Z daily 0.75 https://www.medxy.ai/news/zh/detection-of-%CE%B2-cell-preservation-in-new-onset-td1m 2026-07-10T13:36:11.000Z daily 0.75 https://www.medxy.ai/news/plasma-oxytocin-as-a-superior-preoperative-biomarker 2026-07-10T13:37:44.000Z daily 0.75 https://www.medxy.ai/news/vi/postoperative-arginine-vasopressin-deficiency-following-transsphenoidal-pituitary-surgery 2026-07-10T13:37:37.000Z daily 0.75 https://www.medxy.ai/news/ja/postoperative-arginine-vasopressin-deficiency-in-transsphenoidal-pituitary-surgery 2026-07-10T13:37:31.000Z daily 0.75 https://www.medxy.ai/news/zh/postoperative-arginine-vasopressin-deficiency-in-pituitary-surgery 2026-07-10T13:37:23.000Z daily 0.75 https://www.medxy.ai/news/long-term-economic-impact-of-early-onset-dementia-a-15-year-retrospective-analysis-of-income-and-productivity-loss 2026-07-10T13:39:57.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-economic-impact-of-early-onset-dementia-a-15-year 2026-07-10T18:08:49.000Z daily 0.75 https://www.medxy.ai/news/ja/long-term-economic-impact-of-early-onset-dementia 2026-07-10T18:08:41.000Z daily 0.75 https://www.medxy.ai/news/zh/economic-impact-of-early-onset-dementia 2026-07-10T18:08:33.000Z daily 0.75 https://www.medxy.ai/news/perfusion-imagings-role-in-endovascular-therapy-outcomes-for-posterior-cerebral-artery-stroke 2026-07-10T14:10:25.000Z daily 0.75 https://www.medxy.ai/news/vi/perfusion-imagings-in-endovascular-therapy-outcomes-for-posterior-cerebral-artery-stroke 2026-07-10T18:09:29.000Z daily 0.75 https://www.medxy.ai/news/ja/perfusion-imagings-in-endovascular-therapy-for-posterior-cerebral-artery-stroke 2026-07-10T18:09:51.000Z daily 0.75 https://www.medxy.ai/news/zh/endovascular-therapy-for-posterior-cerebral-artery-stroke 2026-07-10T18:10:03.000Z daily 0.75 https://www.medxy.ai/news/decoding-microbial-shifts-in-postoperative-crohns-disease-insights-into-recurrence-dynamics 2026-07-10T17:58:57.000Z daily 0.75 https://www.medxy.ai/news/vi/decoding-microbial-shifts-in-postoperative-crohns-disease 2026-07-10T18:11:31.000Z daily 0.75 https://www.medxy.ai/news/ja/microbial-shifts-in-postoperative-crohns-disease 2026-07-10T18:11:22.000Z daily 0.75 https://www.medxy.ai/news/zh/microbial-in-postoperative-crohns-disease 2026-07-10T18:10:56.000Z daily 0.75 https://www.medxy.ai/news/unveiling-the-role-of-il-10-neutralising-autoantibodies-in-pediatric-onset-inflammatory-bowel-disease 2026-07-10T18:12:50.000Z daily 0.75 https://www.medxy.ai/news/vi/role-of-il-10-neutralising-autoantibodies-in-pediatric-onset-inflammatory-bowel-disease 2026-07-10T18:15:49.000Z daily 0.75 https://www.medxy.ai/news/ja/il-10-in-pediatric-onset-inflammatory-bowel-disease 2026-07-10T18:15:41.000Z daily 0.75 https://www.medxy.ai/news/zh/il-10-in-inflammatory-bowel-disease 2026-07-10T18:15:27.000Z daily 0.75 https://www.medxy.ai/news/the-critical-role-of-pyruvate-ppar%CE%B1-and-reactive-oxygen-species 2026-07-10T18:19:01.000Z daily 0.75 https://www.medxy.ai/news/vi/pyruvate-ppar%CE%B1-and-reactive-oxygen-species 2026-07-10T18:19:54.000Z daily 0.75 https://www.medxy.ai/news/ja/pyruvate-ppar%CE%B1-and-reactive-oxygen-specie 2026-07-10T18:19:44.000Z daily 0.75 https://www.medxy.ai/news/zh/hbv-pyruvate-ppar%CE%B1-and-reactive-oxygen-specie 2026-07-10T18:20:19.000Z daily 0.75 https://www.medxy.ai/news/persistent-elevated-risk-of-severe-covid-19-outcomes-in-pregnant-and-postpartum-individuals-beyond-the-pandemic-emergency 2026-07-10T19:26:45.000Z daily 0.75 https://www.medxy.ai/news/vi/persistent-elevated-risk-of-severe-covid-19-outcomes-in-pregnant-and-postpartum-individuals 2026-07-10T19:29:10.000Z daily 0.75 https://www.medxy.ai/news/ja/persistent-elevated-risk-of-severe-covid-19-outcomes 2026-07-10T19:29:18.000Z daily 0.75 https://www.medxy.ai/news/zh/elevated-risk-of-severe-covid-19-outcomes 2026-07-10T19:29:24.000Z daily 0.75 https://www.medxy.ai/news/double-vs-single-emergency-cervical-cerclage-with-vaginal-progesterone 2026-07-11T09:26:21.000Z daily 0.75 https://www.medxy.ai/news/vi/pregnancy-outcomes-in-advanced-cervical-insufficiency 2026-07-11T09:27:41.000Z daily 0.75 https://www.medxy.ai/news/ja/double-vs-single-emergency-cervical-cerclage-with-vaginal-progesterone-in-advanced-cervical-insufficiency 2026-07-11T09:27:36.000Z daily 0.75 https://www.medxy.ai/news/zh/double-vs-single-emergency-cervical-cerclage-pregnancy-outcomes-in-advanced-cervical-insufficiency 2026-07-11T09:27:28.000Z daily 0.75 https://www.medxy.ai/news/lithium-use-in-pregnancy 2026-07-11T09:29:18.000Z daily 0.75 https://www.medxy.ai/news/vi/balancing-risks-of-spontaneous-preterm-birth-cardiac-malformations-and-fetal-growth 2026-07-11T09:29:29.000Z daily 0.75 https://www.medxy.ai/news/ja/lithium-use-in-pregnancy-preterm-birth-cardiac-malformations-and-fetal-growth 2026-07-11T09:29:48.000Z daily 0.75 https://www.medxy.ai/news/zh/lithium-risks-of-spontaneous-preterm-birth-cardiac-malformations-and-fetal-growth 2026-07-11T09:30:03.000Z daily 0.75 https://www.medxy.ai/news/immature-ovarian-teratomas-with-microscopic-yolk-sac-tumor-in-children-and-adolescents 2026-07-11T09:42:07.000Z daily 0.75 https://www.medxy.ai/news/vi/yolk-sac-tumor-in-children-and-adolescents 2026-07-11T09:43:12.000Z daily 0.75 https://www.medxy.ai/news/ja/immature-ovarian-teratomas-with-microscopic-yolk-sac-tumor 2026-07-11T09:42:58.000Z daily 0.75 https://www.medxy.ai/news/zh/immature-ovarian-teratomas-with-microscopic-yolk-sac-tumor-in-children 2026-07-11T09:42:36.000Z daily 0.75 https://www.medxy.ai/news/the-incremental-role-of-endoscopic-ultrasound-and-fine-needle-aspiration 2026-07-11T09:43:37.000Z daily 0.75 https://www.medxy.ai/news/vi/role-of-endoscopic-ultrasound-and-fine-needle-aspiration 2026-07-11T09:45:52.000Z daily 0.75 https://www.medxy.ai/news/ja/pancreatic-cystic-neoplasm-via-endoscopic-ultrasound-and-fine-needle-aspiration 2026-07-11T09:45:43.000Z daily 0.75 https://www.medxy.ai/news/zh/pancreatic-cystic-neoplasm-by-endoscopic-ultrasound-and-fine-needle-aspiration 2026-07-11T09:45:29.000Z daily 0.75 https://www.medxy.ai/news/single-encounter-augmented-reality-guided-localization-enhances-early-stage-lung-cancer-resection 2026-07-11T09:51:05.000Z daily 0.75 https://www.medxy.ai/news/vi/reality-guided-localization-enhances-early-stage-lung-cancer-resection 2026-07-11T09:50:55.000Z daily 0.75 https://www.medxy.ai/news/ja/single-encounter-augmented-reality-guided-localization-enhances-lung-cancer-resection 2026-07-11T09:50:44.000Z daily 0.75 https://www.medxy.ai/news/zh/augmented-reality-guided-localization-enhances-early-stage-lung-cancer-resection 2026-07-11T09:50:34.000Z daily 0.75 https://www.medxy.ai/news/sustained-quality-of-life-after-pancreatic-surgery-for-ipmns-in-young-patients 2026-07-11T09:51:16.000Z daily 0.75 https://www.medxy.ai/news/vi/quality-of-life-after-pancreatic-surgery-for-ipmns-in-young-patients 2026-07-11T09:52:21.000Z daily 0.75 https://www.medxy.ai/news/ja/sustained-quality-of-life-after-pancreatic-surgery-for-ipmns 2026-07-11T09:52:13.000Z daily 0.75 https://www.medxy.ai/news/zh/quality-of-life-after-pancreatic-surgery-for-ipmns 2026-07-11T09:51:54.000Z daily 0.75 https://www.medxy.ai/news/a-3d-printed-transoral-device-for-safe-respiratory-monitoring-during-sedation 2026-07-11T09:53:59.000Z daily 0.75 https://www.medxy.ai/news/vi/a-3d-printed-transoral-device-for-safe-respiratory-monitoring 2026-07-11T09:54:49.000Z daily 0.75 https://www.medxy.ai/news/ja/3d-printed-transoral-device-for-safe-respiratory-monitoring-during-sedation 2026-07-11T09:55:08.000Z daily 0.75 https://www.medxy.ai/news/zh/3d-printed-transoral-device-for-respiratory-monitoring 2026-07-11T09:55:37.000Z daily 0.75 https://www.medxy.ai/news/advancing-early-detection-of-nasopharyngeal-carcinoma 2026-07-11T09:56:45.000Z daily 0.75 https://www.medxy.ai/news/vi/anti-bnlf2b-antibody-test-in-advancing-early-detection-of-nasopharyngeal-carcinoma 2026-07-11T09:57:24.000Z daily 0.75 https://www.medxy.ai/news/nicotinamide-supplementation-and-primary-open-angle-glaucoma-in-patients-with-ocular-hypertension 2026-07-11T11:42:29.000Z daily 0.75 https://www.medxy.ai/news/vi/nicotinamide-supplementation-and-primary-open-angle-glaucoma-in-ocular-hypertension 2026-07-11T11:42:44.000Z daily 0.75 https://www.medxy.ai/news/zh/nicotinamide-supplementation-for-primary-open-angle-glaucoma-in-ocular-hypertension 2026-07-11T11:43:08.000Z daily 0.75 https://www.medxy.ai/news/comparing-long-term-systemic-risks-of-biologic-versus-conventional-therapy-in-non-infectious-uveitis 2026-07-11T11:42:02.000Z daily 0.75 https://www.medxy.ai/news/synergistic-impact-of-clonal-hematopoiesis-and-genetic-predisposition-on-age-related-macular-degeneration-risk 2026-07-11T11:48:52.000Z daily 0.75 https://www.medxy.ai/news/vi/clonal-hematopoiesis-and-genetic-predisposition-on-age-related-macular-degeneration-risk 2026-07-11T11:49:56.000Z daily 0.75 https://www.medxy.ai/news/ja/clonal-hematopoiesis-on-age-related-macular-degeneration-risk 2026-07-11T11:50:00.000Z daily 0.75 https://www.medxy.ai/news/zh/genetic-predisposition-on-age-related-macular-degeneration-risk 2026-07-11T11:53:25.000Z daily 0.75 https://www.medxy.ai/news/shared-genetic-foundations-of-idiopathic-pulmonary-fibrosis-in-east-asian-and-european-populations 2026-07-11T11:50:13.000Z daily 0.75 https://www.medxy.ai/news/vi/idiopathic-pulmonary-fibrosis-in-east-asian-and-european-populations 2026-07-12T08:28:41.000Z daily 0.75 https://www.medxy.ai/news/ja/shared-genetic-foundations-of-idiopathic-pulmonary-fibrosis 2026-07-12T08:28:31.000Z daily 0.75 https://www.medxy.ai/news/zh/genetic-foundations-of-idiopathic-pulmonary-fibrosis 2026-07-12T08:28:24.000Z daily 0.75 https://www.medxy.ai/news/optimizing-smoking-cessation-interventions-in-lung-cancer-screening 2026-07-11T11:54:48.000Z daily 0.75 https://www.medxy.ai/news/vi/smoking-cessation-interventions-in-lung-cancer-screening 2026-07-12T08:28:19.000Z daily 0.75 https://www.medxy.ai/news/ja/smoking-cessation-in-lung-cancer-screening 2026-07-12T08:28:09.000Z daily 0.75 https://www.medxy.ai/news/zh/smoking-cessation-for-lung-cancer-screening 2026-07-12T08:28:02.000Z daily 0.75 https://www.medxy.ai/news/decoding-piezo1-variants-precision-insights-into-hereditary-red-blood-cell-and-iron-disorders 2026-07-12T08:27:55.000Z daily 0.75 https://www.medxy.ai/news/vi/decoding-piezo1-variants-precision-into-hereditary-red-blood-cell-and-iron-disorders 2026-07-12T08:27:44.000Z daily 0.75 https://www.medxy.ai/news/ja/piezo1-variants-into-red-blood-cell-and-iron-disorders 2026-07-12T08:30:07.000Z daily 0.75 https://www.medxy.ai/news/zh/piezo1-variants-precision-into-hereditary-red-blood-cell-and-iron-disorders 2026-07-12T08:29:30.000Z daily 0.75 https://www.medxy.ai/news/maipi-a-novel-ai-powered-prognostic-index-for-mantle-cell-lymphoma-using-routine-histology 2026-07-12T08:30:49.000Z daily 0.75 https://www.medxy.ai/news/vi/maipi-prognostic-index-for-mantle-cell-lymphoma-using-routine-histology 2026-07-12T13:06:37.000Z daily 0.75 https://www.medxy.ai/news/ja/maipi-for-mantle-cell-lymphoma-using-routine-histology 2026-07-12T13:06:25.000Z daily 0.75 https://www.medxy.ai/news/zh/maipi-for-mantle-cell-lymphoma 2026-07-12T13:06:28.000Z daily 0.75 https://www.medxy.ai/news/unraveling-genetic-drivers-in-triple-negative-thrombocytosis 2026-07-12T13:07:05.000Z daily 0.75 https://www.medxy.ai/news/vi/genetic-drivers-in-triple-negative-thrombocytosis-mpl-and-sh2b3-lnk-mutations 2026-07-12T13:07:27.000Z daily 0.75 https://www.medxy.ai/news/ja/mpl-and-sh2b3-lnk-mutations-in-triple-negative-thrombocytosis 2026-07-12T13:07:52.000Z daily 0.75 https://www.medxy.ai/news/zh/mpl-and-sh2b3-in-triple-negative-thrombocytosis 2026-07-12T13:08:06.000Z daily 0.75 https://www.medxy.ai/news/fludarabine-with-treosulfan-vs-total-body-irradiation-as-conditioning-in-all-transplantation 2026-07-12T13:08:55.000Z daily 0.75 https://www.medxy.ai/news/vi/fludarabine-with-treosulfan-vs-total-body-irradiation 2026-07-12T13:09:58.000Z daily 0.75 https://www.medxy.ai/news/patient-centered-prescription-opioid-tapering-rct 2026-07-12T17:32:40.000Z daily 0.75 https://www.medxy.ai/news/expanding-contraceptive-access-in-veterans-affairs-pharmacist-led-hormonal-contraception-provision-and-12-month-dispensing-pilot 2026-07-12T17:31:37.000Z daily 0.75 https://www.medxy.ai/news/vi/expanding-contraceptive-access-in-veterans-affairs-pharmacist-led-hormonal-contraception-provision 2026-07-12T17:35:49.000Z daily 0.75 https://www.medxy.ai/news/ja/pharmacist-led-hormonal-contraception-provision-and-12-month-dispensing-pilot 2026-07-12T17:35:37.000Z daily 0.75 https://www.medxy.ai/news/zh/contraceptive-access-in-veterans-affairs-pharmacist-led-hormonal-contraception-provision-and-12-month-dispensing-pilot 2026-07-12T17:35:26.000Z daily 0.75 https://www.medxy.ai/news/transforming-emergency-psychiatric-care 2026-07-12T17:37:14.000Z daily 0.75 https://www.medxy.ai/news/vi/emergency-psychiatric-care 2026-07-12T17:38:22.000Z daily 0.75 https://www.medxy.ai/news/ja/transforming-emergency-psychiatric-care-staffing-model-cuts-length-of-stay 2026-07-12T17:39:00.000Z daily 0.75 https://www.medxy.ai/news/zh/staffing-model-cuts-length-of-stay-in-transforming-emergency-psychiatric-care 2026-07-12T17:39:19.000Z daily 0.75 https://www.medxy.ai/news/abcdef-bundle-in-icus-impacts-on-delirium-functional-status 2026-07-12T17:40:23.000Z daily 0.75 https://www.medxy.ai/news/vi/the-abcdef-bundle-impacts-on-delirium-functional-status-and-long-term-quality-of-life 2026-07-12T17:41:35.000Z daily 0.75 https://www.medxy.ai/news/ja/the-abcdef-bundle-impacts-on-delirium-functional-status-and-quality-of-life 2026-07-12T17:41:20.000Z daily 0.75 https://www.medxy.ai/news/zh/the-abcdef-bundle-on-delirium-functional-status-and-quality-of-life 2026-07-12T17:41:07.000Z daily 0.75 https://www.medxy.ai/news/adolescent-mental-health-care-and-stigma 2026-07-12T17:42:15.000Z daily 0.75 https://www.medxy.ai/news/vi/adolescent-mental-health-care-and-stigma-from-the-artemis-randomized-clinical-trial 2026-07-12T17:43:27.000Z daily 0.75 https://www.medxy.ai/news/ja/adolescent-mental-health-care-and-stigma-from-the-artemis-trial 2026-07-12T17:43:08.000Z daily 0.75 https://www.medxy.ai/news/integrating-trauma-focused-therapy-with-cognitive-behavioural-therapy-for-psychosis-insights 2026-07-12T17:46:43.000Z daily 0.75 https://www.medxy.ai/news/vi/integrating-trauma-focused-therapy-with-cognitive-behavioural-therapy-for-psychosis-from-the-star-trial 2026-07-12T17:47:06.000Z daily 0.75 https://www.medxy.ai/news/ja/integrating-trauma-focused-therapy-with-cognitive-behavioural-therapy-for-psychosis 2026-07-12T17:47:18.000Z daily 0.75 https://www.medxy.ai/news/integrating-trauma-focused-therapy-with-cognitive-behavioural-therapy-for-psychosis-insights-from-star-trial 2026-07-12T17:47:59.000Z daily 0.75 https://www.medxy.ai/news/comparative-efficacy-and-pragmatic-implications-of-walant-versus-general-and-regional-anesthesia-in-flexor-tendon-repair 2026-07-12T17:49:47.000Z daily 0.75 https://www.medxy.ai/news/high-frequency-ultrasound-in-managing-palpable-indurations-after-cosmetic-filler-injections 2026-07-12T17:52:20.000Z daily 0.75 https://www.medxy.ai/news/vi/high-frequency-ultrasound-in-managing-palpable-indurations-after-cosmetic 2026-07-12T17:53:22.000Z daily 0.75 https://www.medxy.ai/news/ja/high-frequency-ultrasound-in-managing-palpable-indurations 2026-07-12T17:54:36.000Z daily 0.75 https://www.medxy.ai/news/zh/high-frequency-ultrasound-in-palpable-indurations-after-cosmetic-filler-injections 2026-07-12T17:55:14.000Z daily 0.75 https://www.medxy.ai/news/feasibility-and-comparative-outcomes-of-24-week-abrocitinib-tapering-in-moderate-to-severe-atopic-dermatitis 2026-07-12T17:51:45.000Z daily 0.75 https://www.medxy.ai/news/when-to-image-expert-consensus-on-staging-and-surveillance-imaging-for-cutaneous-squamous-cell-carcinoma 2026-07-12T18:00:23.000Z daily 0.75 https://www.medxy.ai/news/zh/expert-consensus-on-staging-and-surveillance-imaging-for-cutaneous-squamous-cell-carcinoma 2026-07-12T18:03:38.000Z daily 0.75 https://www.medxy.ai/news/vi/consensus-on-staging-and-surveillance-imaging-for-cutaneous-squamous-cell-carcinoma 2026-07-12T18:04:09.000Z daily 0.75 https://www.medxy.ai/news/optimizing-long-term-management-in-moderate-to-severe-atopic-dermatitis 2026-07-12T18:07:04.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-management-in-moderate-to-severe-atopic-dermatitis 2026-07-12T18:07:23.000Z daily 0.75 https://www.medxy.ai/news/ja/long-term-management-in-moderate-to-severe-atopic-dermatitis-real-world-evidence-on-24-week-abrocitinib-tapering 2026-07-12T18:07:55.000Z daily 0.75 https://www.medxy.ai/news/zh/long-term-management-in-moderate-to-severe-atopic-dermatitis-real-world-evidence-on-24-week-abrocitinib 2026-07-12T18:08:17.000Z daily 0.75 https://www.medxy.ai/news/durvalumab-plus-chemotherapy-extends-survival-in-advanced-biliary-tract-cancer 2026-07-12T19:13:00.000Z daily 0.75 https://www.medxy.ai/news/vi/durvalumab-plus-chemotherapy-in-advanced-biliary-tract-cancer 2026-07-12T19:14:08.000Z daily 0.75 https://www.medxy.ai/news/ja/durvalumab-plus-chemotherapy-in-advanced-biliary-tract-cancer-2 2026-07-12T19:14:01.000Z daily 0.75 https://www.medxy.ai/news/zh/durvalumab-%E8%81%94%E5%90%88%E5%8C%96%E7%96%97%E5%BB%B6%E9%95%BF%E6%99%9A%E6%9C%9F%E8%83%86%E9%81%93%E7%99%8C%E7%94%9F%E5%AD%98%EF%BC%9Atopaz-1-%E8%AF%95%E9%AA%8C4%E5%B9%B4%E4%BA%8B%E5%90%8E%E5%88%86 2026-07-12T19:12:55.000Z daily 0.75 https://www.medxy.ai/news/unraveling-cardiovascular-health-improvements-post-antihypertensive-intervention-insights-from-the-crhcp-trial 2026-07-12T19:15:38.000Z daily 0.75 https://www.medxy.ai/news/vi/cardiovascular-health-improvements-post-antihypertensive-intervention-the-crhcp-trial 2026-07-12T19:19:46.000Z daily 0.75 https://www.medxy.ai/news/ja/crhcp-trial-cardiovascular-health-improvements-post-antihypertensive-intervention 2026-07-12T19:21:52.000Z daily 0.75 https://www.medxy.ai/news/zh/crhcp-trial-cardiovascular-health-post-antihypertensive-intervention 2026-07-12T19:21:45.000Z daily 0.75 https://www.medxy.ai/news/assessing-cardiovascular-risk-in-first-degree-relatives-of-individuals-with-elevated-lipoproteina 2026-07-12T19:21:31.000Z daily 0.75 https://www.medxy.ai/news/evaluating-the-impact-of-the-resuscitation-quality-improvement-program-on-in-hospital-cardiac-arrest-outcomes 2026-07-12T19:22:46.000Z daily 0.75 https://www.medxy.ai/news/refining-hba1c-thresholds-for-accurate-type-1-diabetes-progression-risk-in-islet-autoantibody-positive-adults 2026-07-12T19:24:34.000Z daily 0.75 https://www.medxy.ai/news/vi/refining-hba1c-thresholds-for-accurate-type-1-diabetes-progression-risk 2026-07-12T19:26:38.000Z daily 0.75 https://www.medxy.ai/news/ja/hba1c-thresholds-for-accurate-type-1-diabetes-progression-risk 2026-07-12T19:26:54.000Z daily 0.75 https://www.medxy.ai/news/zh/hba1c-thresholds-for-accurate-type-1-diabetes-progression-risk-in-adults 2026-07-12T19:27:16.000Z daily 0.75 https://www.medxy.ai/news/neurodevelopmental-outcomes-of-children-conceived-post-hysterosalpingography-with-iodinated-contrast 2026-07-12T20:43:03.000Z daily 0.75 https://www.medxy.ai/news/vi/children-conceived-post-hysterosalpingography-with-iodinated-contrast 2026-07-12T20:39:46.000Z daily 0.75 https://www.medxy.ai/news/ja/neurodevelopmental-outcomes-of-children-iodinated-contrast 2026-07-12T20:39:34.000Z daily 0.75 https://www.medxy.ai/news/zh/neurodevelopmental-outcomes-of-post-hysterosalpingography-with-iodinated-contrast 2026-07-12T20:42:47.000Z daily 0.75 https://www.medxy.ai/news/timing-matters-how-premeal-insulin-enhances-postprandial-glucose-control-and-myocardial-microvascular-blood-flow-in-type-1-diabetes 2026-07-13T09:31:41.000Z daily 0.75 https://www.medxy.ai/news/vi/premeal-insulin-enhances-postprandial-glucose-control-and-myocardial-microvascular-blood-flow-in-type-1-diabetes 2026-07-13T10:18:45.000Z daily 0.75 https://www.medxy.ai/news/ja/premeal-insulin-enhances-postprandial-glucose-control-and-myocardial-microvascular-blood-flow-in-t1dm 2026-07-13T10:19:31.000Z daily 0.75 https://www.medxy.ai/news/zh/premeal-insulin-enhances-postprandial-glucose-and-myocardial-microvascular-blood-flow-in-t1dm 2026-07-13T10:20:25.000Z daily 0.75 https://www.medxy.ai/news/sex-differences-in-large-vessel-occlusion-screening-and-thrombectomy-outcomes-insights-from-a-population-based-cohort-study-in-ontario 2026-07-13T09:57:52.000Z daily 0.75 https://www.medxy.ai/news/vi/sex-differences-in-large-vessel-occlusion-screening-and-thrombectomy-outcomes 2026-07-13T10:20:54.000Z daily 0.75 https://www.medxy.ai/news/ja/sex-differences-in-large-vessel-occlusion-screening-thrombectomy-outcomes 2026-07-13T10:21:10.000Z daily 0.75 https://www.medxy.ai/news/zh/sex-differences-in-large-vessel-occlusion-screening-and-thrombectomy 2026-07-13T10:21:35.000Z daily 0.75 https://www.medxy.ai/news/evaluating-dose-intensification-strategies-for-ustekinumab-in-crohns-disease-insights-from-the-rescue-trial 2026-07-13T10:18:13.000Z daily 0.75 https://www.medxy.ai/news/vi/evaluating-dose-intensification-strategies-for-ustekinumab-in-crohns-disease 2026-07-13T10:22:39.000Z daily 0.75 https://www.medxy.ai/news/ja/dose-intensification-strategies-for-ustekinumab-in-crohns-disease 2026-07-13T10:22:31.000Z daily 0.75 https://www.medxy.ai/news/zh/dose-strategies-for-ustekinumab-in-crohns-disease 2026-07-13T10:22:25.000Z daily 0.75 https://www.medxy.ai/news/unraveling-ibs-genetics-insights-into-cardiometabolic-and-triglyceride-linked-mechanisms-from-a-large-gwas-meta-analysis 2026-07-13T10:22:51.000Z daily 0.75 https://www.medxy.ai/news/vi/ibs-genetics-insights-into-cardiometabolic-and-triglyceride 2026-07-13T10:24:54.000Z daily 0.75 https://www.medxy.ai/news/serum-bile-acid-levels-as-early-predictors-of-portal-hypertension-and-esophageal-varices-post-kasai-in-biliary-atresia 2026-07-13T10:26:13.000Z daily 0.75 https://www.medxy.ai/news/vi/bile-acid-levels-as-early-predictors-of-portal-hypertension-and-esophageal-varices-post-kasai-in-biliary-atresia 2026-07-13T12:44:57.000Z daily 0.75 https://www.medxy.ai/news/ja/serum-bile-acid-as-early-predictors-of-portal-hypertension-and-esophageal-varices-post-kasai-in-biliary-atresia 2026-07-13T12:45:28.000Z daily 0.75 https://www.medxy.ai/news/zh/bile-acid-predict-portal-hypertension-and-esophageal-varices-post-kasai-in-biliary-atresia 2026-07-13T12:46:07.000Z daily 0.75 https://www.medxy.ai/news/comparing-long-term-efficacy-and-safety-of-native-tissue-hysteropexy-versus-hysterectomy-for-apical-pelvic-organ-prolapse 2026-07-13T12:46:25.000Z daily 0.75 https://www.medxy.ai/news/vi/efficacy-and-safety-of-native-tissue-hysteropexy-versus-hysterectomy-for-apical-pelvic-organ-prolapse 2026-07-13T12:46:44.000Z daily 0.75 https://www.medxy.ai/news/ja/efficacy-and-safety-of-native-tissue-hysteropexy-for-apical-pelvic-organ-prolapse 2026-07-13T12:47:09.000Z daily 0.75 https://www.medxy.ai/news/zh/efficacy-of-native-tissue-hysteropexy-for-apical-pelvic-organ-prolapse 2026-07-13T12:48:15.000Z daily 0.75 https://www.medxy.ai/news/ischemic-placental-disease-and-maternal-hospitalization-for-neurological-and-psychiatric-disorders 2026-07-13T13:03:48.000Z daily 0.75 https://www.medxy.ai/news/vi/ischemic-placental-disease-for-neurological-and-psychiatric-disorders 2026-07-13T12:48:55.000Z daily 0.75 https://www.medxy.ai/news/long-term-outcomes-of-retropubic-vs-transobturator-midurethral-slings-for-stress-urinary-incontinence 2026-07-13T13:03:32.000Z daily 0.75 https://www.medxy.ai/news/vi/retropubic-vs-transobturator-midurethral-slings-for-stress-urinary-incontinence 2026-07-13T13:03:21.000Z daily 0.75 https://www.medxy.ai/news/ja/long-term-outcomes-of-retropubic-for-stress-urinary-incontinence 2026-07-13T13:03:07.000Z daily 0.75 https://www.medxy.ai/news/zh/outcomes-of-retropubic-for-stress-urinary-incontinence 2026-07-13T13:02:49.000Z daily 0.75 https://www.medxy.ai/news/assessing-readability-of-gynecologic-cancer-patient-education-materials 2026-07-13T12:59:23.000Z daily 0.75 https://www.medxy.ai/news/vi/readability-of-gynecologic-cancer-patient-education-materials 2026-07-13T13:14:57.000Z daily 0.75 https://www.medxy.ai/news/ja/readability-of-gynecologic-cancer-patient-education 2026-07-13T13:02:27.000Z daily 0.75 https://www.medxy.ai/news/zh/assessing-readability-of-gynecologic-cancer-patient-education 2026-07-13T13:02:05.000Z daily 0.75 https://www.medxy.ai/news/high-trauma-volume-hospitals-and-their-impact-on-prompt-surgical-management-in-blunt-intestinal-injury 2026-07-13T12:59:12.000Z daily 0.75 https://www.medxy.ai/news/vi/high-trauma-volume-hospitals-impact-on-prompt-surgical-management-in-blunt-intestinal-injury 2026-07-13T13:14:44.000Z daily 0.75 https://www.medxy.ai/news/ja/high-trauma-volume-hospitals-on-prompt-surgical-management-in-blunt-intestinal-injury 2026-07-13T13:14:36.000Z daily 0.75 https://www.medxy.ai/news/zh/high-trauma-volume-hospitals-in-blunt-intestinal-injury 2026-07-13T13:04:43.000Z daily 0.75 https://www.medxy.ai/news/nationwide-multimodal-prehabilitation-significantly-reduces-complications-after-colorectal-cancer-surgery 2026-07-13T13:01:50.000Z daily 0.75 https://www.medxy.ai/news/vi/nationwide-multimodal-prehabilitation-reduces-complications-after-colorectal-cancer-surgery 2026-07-13T13:14:25.000Z daily 0.75 https://www.medxy.ai/news/ja/nationwide-multimodal-prehabilitation-reduces-complications-in-colorectal-cancer-surgery 2026-07-13T13:14:14.000Z daily 0.75 https://www.medxy.ai/news/optimizing-prognostic-accuracy-in-duodenal-adenocarcinoma-evaluating-lymph-node-staging-schemes 2026-07-13T13:13:54.000Z daily 0.75 https://www.medxy.ai/news/clinical-and-polysomnographic-characteristics-distinguishing-extreme-from-very-severe-pediatric-obstructive-sleep-apnea 2026-07-13T13:13:12.000Z daily 0.75 https://www.medxy.ai/news/vi/clinical-and-polysomnographic-characteristics-in-very-severe-pediatric-obstructive-sleep-apnea 2026-07-13T13:19:30.000Z daily 0.75 https://www.medxy.ai/news/ja/clinical-and-polysomnographic-characteristics-in-pediatric-obstructive-sleep-apnea 2026-07-13T13:20:14.000Z daily 0.75 https://www.medxy.ai/news/zh/polysomnographic-characteristics-in-pediatric-obstructive-sleep-apnea 2026-07-13T13:20:36.000Z daily 0.75 https://www.medxy.ai/news/hypoglossal-nerve-stimulation-significantly-lowers-hypoxic-burden-and-improves-sleepiness-in-obstructive-sleep-apnea-patients-insights-from-the-star-trial 2026-07-13T13:15:54.000Z daily 0.75 https://www.medxy.ai/news/vi/hypoglossal-nerve-stimulation-significantly-lowers-hypoxic-burden-and-improves-sleepiness-in-obstructive-sleep-apnea-patients 2026-07-13T13:22:45.000Z daily 0.75 https://www.medxy.ai/news/ja/hypoglossal-nerve-stimulation-lowers-hypoxic-burden-and-improves-sleepiness-in-obstructive-sleep-apnea-patients 2026-07-13T13:22:37.000Z daily 0.75 https://www.medxy.ai/news/zh/hypoglossal-nerve-stimulation-lowers-obstructive-sleep-apnea-patients 2026-07-13T13:22:30.000Z daily 0.75 https://www.medxy.ai/news/vi/visual-electrophysiology-in-glaucoma 2026-07-13T13:24:27.000Z daily 0.75 https://www.medxy.ai/news/zh/visual-electrophysiology-in-glaucoma-2 2026-07-13T13:25:40.000Z daily 0.75 https://www.medxy.ai/news/vi/visual-electrophysiology-in-glaucoma-3 2026-07-13T13:26:53.000Z daily 0.75 https://www.medxy.ai/news/ja/visual-electrophysiology-in-glaucoma-4 2026-07-13T13:26:48.000Z daily 0.75 https://www.medxy.ai/news/distinct-ocular-symptom-trajectories-after-refractive-surgery 2026-07-13T13:35:51.000Z daily 0.75 https://www.medxy.ai/news/vi/ocular-symptom-trajectories-after-refractive-surgery 2026-07-13T13:36:02.000Z daily 0.75 https://www.medxy.ai/news/tomographic-predictors-of-foveal-versus-extrafoveal-atrophy-onset-in-intermediate-age-related-macular-degeneration 2026-07-13T13:36:32.000Z daily 0.75 https://www.medxy.ai/news/vi/tomographic-predictors-of-atrophy-onset-in-intermediate-age-related-macular-degeneration 2026-07-13T13:36:57.000Z daily 0.75 https://www.medxy.ai/news/ja/tomographic-predictors-of-foveal-versus-extrafoveal-atrophy-onset-in-age-related-macular-degeneration 2026-07-13T13:37:20.000Z daily 0.75 https://www.medxy.ai/news/unlocking-lung-repair-prostaglandin-i2-receptor-activation-drives-alveolar-regeneration-via-jun-p53-pathway 2026-07-13T13:35:32.000Z daily 0.75 https://www.medxy.ai/news/vi/prostaglandin-i2-receptor-activation-drives-alveolar-regeneration-via-jun-p53-pathway 2026-07-13T13:38:15.000Z daily 0.75 https://www.medxy.ai/news/ja/prostaglandin-i2-receptor-activation-drives-alveolar-regeneration-via-jun-p53-pathway-for-lung-repair 2026-07-13T13:39:01.000Z daily 0.75 https://www.medxy.ai/news/zh/prostaglandin-i2-receptor-jun-p53-pathway-drives-alveolar-regeneration-for-lung-repair 2026-07-13T13:39:40.000Z daily 0.75 https://www.medxy.ai/news/cardiac-alterations-in-swimming-induced-pulmonary-edema 2026-07-13T13:40:07.000Z daily 0.75 https://www.medxy.ai/news/vi/cardiac-alterations-in-swimming-induced-pulmonary-edema-2 2026-07-13T13:40:53.000Z daily 0.75 https://www.medxy.ai/news/ja/cardiac-alterations-in-swimming-induced-pulmonary-edema-3 2026-07-13T13:40:58.000Z daily 0.75 https://www.medxy.ai/news/zh/cardiac-alterations-in-swimming-induced-pulmonary-edema-4 2026-07-13T13:41:12.000Z daily 0.75 https://www.medxy.ai/news/pavurutamab-a-bcma-targeting-bispecific-t-cell-engager-promising-phase-1-1b-results-in-triple-class-relapsed-refractory-multiple-myeloma 2026-07-13T13:39:56.000Z daily 0.75 https://www.medxy.ai/news/vi/pavurutamab-in-triple-class-relapsed-refractory-multiple-myeloma 2026-07-13T13:42:32.000Z daily 0.75 https://www.medxy.ai/news/ja/pavurutamab-in-triple-class-relapsed-refractory-multiple-myeloma-2 2026-07-13T13:42:22.000Z daily 0.75 https://www.medxy.ai/news/zh/pavurutamab-in-triple-class-relapsed-refractory-multiple-myeloma-3 2026-07-13T13:42:55.000Z daily 0.75 https://www.medxy.ai/news/cd7-directed-car-t-cell-therapy-in-relapsed-refractory-cd7-positive-acute-myeloid-leukemia-clinical-advances-and-future-perspectives 2026-07-13T13:43:08.000Z daily 0.75 https://www.medxy.ai/news/vi/cd7-directed-car-t-cell-therapy-in-relapsed-refractory-cd7-positive-acute-myeloid-leukemia 2026-07-13T13:58:06.000Z daily 0.75 https://www.medxy.ai/news/ja/cd7-directed-car-t-cell-therapy-in-relapsed-refractory-acute-myeloid-leukemia 2026-07-13T13:58:29.000Z daily 0.75 https://www.medxy.ai/news/zh/cd7-car-t-cell-therapy-in-relapsed-refractory-cd7-positive-acute-myeloid-leukemia 2026-07-13T13:58:43.000Z daily 0.75 https://www.medxy.ai/news/early-software-assisted-evaluation-enhances-prediction-of-survival-in-newly-diagnosed-chronic-graft-versus-host-disease-patients 2026-07-13T13:57:17.000Z daily 0.75 https://www.medxy.ai/news/vi/prediction-of-survival-in-newly-diagnosed-chronic-graft-versus-host-disease-patients 2026-07-13T13:59:11.000Z daily 0.75 https://www.medxy.ai/news/physical-restraint-use-in-mechanically-ventilated-icu-patients-impact-on-delirium-and-coma-free-days-over-14-days 2026-07-14T07:32:01.000Z daily 0.75 https://www.medxy.ai/news/vi/physical-restraint-use-in-mechanically-ventilated-icu-patients 2026-07-14T07:31:54.000Z daily 0.75 https://www.medxy.ai/news/ja/physical-restraint-use-in-mechanically-ventilated-icu-patients-free-days-over-14-days 2026-07-14T07:32:14.000Z daily 0.75 https://www.medxy.ai/news/zh/physical-restraint-use-in-mechanically-ventilated-icu-patients-impact-on-delirium-and-coma 2026-07-14T07:32:32.000Z daily 0.75 https://www.medxy.ai/news/enhancing-suicide-prevention-teen-and-caregiver-views-on-lethal-means-safety-planning-in-the-emergency-department 2026-07-14T08:19:45.000Z daily 0.75 https://www.medxy.ai/news/vi/enhancing-suicide-prevention-teen-and-caregiver-in-the-emergency-department 2026-07-14T08:27:59.000Z daily 0.75 https://www.medxy.ai/news/ja/enhancing-suicide-prevention-of-teen-and-caregiver-in-the-emergency-department 2026-07-14T08:34:34.000Z daily 0.75 https://www.medxy.ai/news/zh/suicide-prevention-of-teen-and-caregiver-in-the-emergency-department 2026-07-14T08:28:48.000Z daily 0.75 https://www.medxy.ai/news/sex-differences-in-critical-care-outcomes 2026-07-14T08:33:02.000Z daily 0.75 https://www.medxy.ai/news/vi/sex-differences-in-critical-care-outcomes-in-india 2026-07-14T08:33:25.000Z daily 0.75 https://www.medxy.ai/news/ja/sex-differences-in-critical-care-outcomes-2 2026-07-14T08:33:54.000Z daily 0.75 https://www.medxy.ai/news/zh/sex-differences-in-critical-care-outcomes-3 2026-07-14T08:34:10.000Z daily 0.75 https://www.medxy.ai/news/comparative-effectiveness-of-dialectical-behavior-therapy-and-schema-therapy-in-borderline-personality-disorder 2026-07-14T08:34:51.000Z daily 0.75 https://www.medxy.ai/news/vi/effectiveness-of-dialectical-behavior-therapy-and-schema-therapy-in-borderline-personality-disorder 2026-07-14T08:38:41.000Z daily 0.75 https://www.medxy.ai/news/evaluating-the-economic-impact-of-enhanced-primary-youth-mental-health-services-insights-from-the-access-open-minds-study 2026-07-14T09:07:54.000Z daily 0.75 https://www.medxy.ai/news/vi/evaluating-the-economic-impact-of-enhanced-primary-youth-mental-health-services 2026-07-14T09:22:08.000Z daily 0.75 https://www.medxy.ai/news/ja/enhanced-primary-youth-mental-health-services 2026-07-14T09:22:25.000Z daily 0.75 https://www.medxy.ai/news/zh/the-economic-impact-of-enhanced-primary-youth-mental-health-services 2026-07-14T09:22:43.000Z daily 0.75 https://www.medxy.ai/news/enhancing-facial-reanimation-outcomes-the-impact-of-fascia-lata-suspension-in-triple-nerve-transfer-procedures 2026-07-14T09:15:37.000Z daily 0.75 https://www.medxy.ai/news/vi/facial-reanimation-outcomes-the-impact-of-fascia-lata-suspension-in-triple-nerve-transfer-procedures 2026-07-14T09:23:06.000Z daily 0.75 https://www.medxy.ai/news/ja/facial-reanimation-outcomes-the-impact-of-fascia-lata-suspension-in-triple-nerve-transfer 2026-07-14T09:23:36.000Z daily 0.75 https://www.medxy.ai/news/zh/facial-reanimation-outcomes-of-fascia-lata-suspension-in-triple-nerve-transfer-procedures 2026-07-14T09:24:00.000Z daily 0.75 https://www.medxy.ai/news/navigating-patient-misconceptions-about-hyaluronic-acid-fillers-for-optimal-aesthetic-outcomes 2026-07-14T09:35:20.000Z daily 0.75 https://www.medxy.ai/news/vi/navigating-patient-misconceptions-about-hyaluronic-acid-for-optimal-aesthetic-outcomes 2026-07-14T09:35:41.000Z daily 0.75 https://www.medxy.ai/news/ja/navigating-patient-misconceptions-about-hyaluronic-acid-fillers-for-aesthetic-outcomes 2026-07-14T09:36:06.000Z daily 0.75 https://www.medxy.ai/news/zh/misconceptions-about-hyaluronic-acid-fillers-for-optimal-aesthetic-outcomes 2026-07-14T09:36:28.000Z daily 0.75 https://www.medxy.ai/news/exploring-institutional-and-insurance-linked-disparities-in-melanoma-outcomes-insights-from-a-va-and-tertiary-care-cohort-study 2026-07-14T09:36:47.000Z daily 0.75 https://www.medxy.ai/news/vi/exploring-institutional-and-insurance-linked-disparities-in-melanoma-outcomes 2026-07-14T09:57:08.000Z daily 0.75 https://www.medxy.ai/news/ja/institutional-and-insurance-linked-disparities-in-melanoma-outcomes-insights-from-a-va-and-tertiary-care-cohort-study 2026-07-14T09:57:31.000Z daily 0.75 https://www.medxy.ai/news/zh/institutional-and-insurance-linked-disparities-in-melanoma-outcomes 2026-07-14T09:57:51.000Z daily 0.75 https://www.medxy.ai/news/circulating-tumor-dna-outperforms-merkel-cell-polyomavirus-antibodies-for-monitoring-recurrence-in-merkel-cell-carcinoma 2026-07-14T10:28:43.000Z daily 0.75 https://www.medxy.ai/news/vi/ctdna-outperforms-merkel-cell-polyomavirus-antibodies-for-monitoring-recurrence-in-merkel-cell-carcinoma 2026-07-14T10:28:38.000Z daily 0.75 https://www.medxy.ai/news/ja/ctdna-outperforms-merkel-cell-polyomavirus-antibodies-for-recurrence-in-merkel-cell-carcinoma 2026-07-14T10:29:09.000Z daily 0.75 https://www.medxy.ai/news/zh/ctdna-outperforms-for-monitoring-recurrence-in-merkel-cell-carcinoma 2026-07-14T10:29:29.000Z daily 0.75 https://www.medxy.ai/news/evaluating-consolidative-thoracic-radiotherapy-with-atezolizumab-maintenance-in-extensive-stage-small-cell-lung-cancer 2026-07-14T12:57:55.000Z daily 0.75 https://www.medxy.ai/news/vi/consolidative-thoracic-radiotherapy-with-atezolizumab-maintenance-in-extensive-stage-small-cell-lung-cancer 2026-07-14T12:58:13.000Z daily 0.75 https://www.medxy.ai/news/ja/consolidative-thoracic-radiotherapy-with-atezolizumab-maintenance-in-extensive-stage-sclc 2026-07-14T12:59:00.000Z daily 0.75 https://www.medxy.ai/news/zh/consolidative-thoracic-radiotherapy-with-atezolizumab-maintenance-in-es-sclc 2026-07-14T12:59:16.000Z daily 0.75 https://www.medxy.ai/news/microplastic-exposure-and-cardiomyopathy-unveiling-the-gut-heart-axis-mechanism 2026-07-14T12:47:08.000Z daily 0.75 https://www.medxy.ai/news/vi/microplastic-exposure-and-cardiomyopathy-unveiling-the-gut-heart-axis 2026-07-14T12:59:34.000Z daily 0.75 https://www.medxy.ai/news/orbita-cto-trial-evaluating-the-impact-of-percutaneous-coronary-intervention-on-symptomatic-chronic-total-occlusion-in-stable-angina 2026-07-14T13:02:19.000Z daily 0.75 https://www.medxy.ai/news/vi/orbita-cto-trial-evaluating-percutaneous-coronary-intervention-on-symptomatic-chronic-total-occlusion-in-stable-angina 2026-07-14T13:04:00.000Z daily 0.75 https://www.medxy.ai/news/ja/orbita-cto%E8%A9%A6%E9%A8%93%EF%BC%9A%E5%AE%89%E5%AE%9A%E7%8B%AD%E5%BF%83%E7%97%87%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E7%97%87%E5%80%99%E6%80%A7%E6%85%A2%E6%80%A7%E5%AE%8C%E5%85%A8%E9%96%89%E5%A1%9E 2026-07-14T13:03:20.000Z daily 0.75 https://www.medxy.ai/news/zh/orbita-cto-evaluating-percutaneous-coronary-intervention-on-symptomatic-chronic-total-occlusion-in-stable-angina 2026-07-14T13:04:37.000Z daily 0.75 https://www.medxy.ai/news/wine-consumption-mediterranean-diet-and-cardiovascular-risk-in-two-spanish-cohorts 2026-07-14T13:07:10.000Z daily 0.75 https://www.medxy.ai/news/vi/wine-consumption-mediterranean-diet-and-cardiovascular-risk 2026-07-14T13:09:04.000Z daily 0.75 https://www.medxy.ai/news/ja/wine-consumption-mediterranean-diet-and-cardiovascular-disease 2026-07-14T13:09:37.000Z daily 0.75 https://www.medxy.ai/news/maternal-diabetes-and-the-elevated-risk-of-early-onset-cardiovascular-disease-in-offspring-insights-from-a-swedish-nationwide-cohort-study 2026-07-14T13:36:06.000Z daily 0.75 https://www.medxy.ai/news/vi/maternal-diabetes-and-the-elevated-risk-of-early-onset-cardiovascular-disease-in-offspring 2026-07-14T14:04:53.000Z daily 0.75 https://www.medxy.ai/news/ja/maternal-diabetes-and-the-risk-of-early-onset-cardiovascular-disease-in-offspring 2026-07-14T14:04:42.000Z daily 0.75 https://www.medxy.ai/news/zh/maternal-diabetes-increase-the-risk-of-early-onset-cardiovascular-disease-in-offspring 2026-07-14T14:04:26.000Z daily 0.75 https://www.medxy.ai/news/herzcheck-revolutionizing-early-detection-of-subclinical-preheart-failure-in-rural-regions-via-mobile-cardiac-mri-and-telemedicine 2026-07-14T14:03:30.000Z daily 0.75 https://www.medxy.ai/news/vi/early-detection-of-subclinical-preheart-failure-in-rural-regions-via-mobile-cardiac-mri-and-telemedicine 2026-07-14T14:05:17.000Z daily 0.75 https://www.medxy.ai/news/exploring-low-dose-antithymocyte-globulin-therapy-in-type-1-diabetes-real-world-insights-using-modified-quantitative-response-of-c-peptide 2026-07-14T14:07:05.000Z daily 0.75 https://www.medxy.ai/news/vi/low-dose-antithymocyte-globulin-therapy-in-type-1-diabetes-real-world-insights-using-modified-quantitative-response-of-c-peptide 2026-07-14T14:08:40.000Z daily 0.75 https://www.medxy.ai/news/next-generation-pharmacotherapies-in-obesity-transforming-care-with-precision-and-multisystem-benefits 2026-07-14T14:08:16.000Z daily 0.75 https://www.medxy.ai/news/vi/next-generation-pharmacotherapies-in-obesity-transforming-care-with-precision-and-multisystem-benefits-2 2026-07-14T14:44:05.000Z daily 0.75 https://www.medxy.ai/news/ja/pharmacotherapies-in-obesity-transforming-care-with-precision-and-multisystem-benefits 2026-07-14T14:44:23.000Z daily 0.75 https://www.medxy.ai/news/zh/next-generation-pharmacotherapies-in-obesity-transforming-care 2026-07-14T14:44:39.000Z daily 0.75 https://www.medxy.ai/news/distinct-immune-subtypes-in-type-1-diabetes-implications-for-disease-progression-and-personalized-immunotherapy 2026-07-14T16:55:44.000Z daily 0.75 https://www.medxy.ai/news/vi/immune-subtypes-in-type-1-diabetes-implications-for-disease-progression-and-personalized-immunotherapy 2026-07-14T16:58:55.000Z daily 0.75 https://www.medxy.ai/news/ja/immune-subtypes-in-type-1-diabetes 2026-07-14T16:59:12.000Z daily 0.75 https://www.medxy.ai/news/zh/immune-subtypes-in-t1dm 2026-07-14T16:59:35.000Z daily 0.75 https://www.medxy.ai/news/acute-neural-biomarker-elevations-after-amateur-soccer-heading-insights-into-potential-brain-injury 2026-07-14T17:05:25.000Z daily 0.75 https://www.medxy.ai/news/vi/acute-neural-biomarker-elevations-after-amateur-soccer-heading 2026-07-14T17:05:19.000Z daily 0.75 https://www.medxy.ai/news/ja/acute-neural-biomarker-after-amateur-soccer-heading 2026-07-14T17:05:52.000Z daily 0.75 https://www.medxy.ai/news/zh/acute-neural-biomarker-elevations-after-amateur-soccer-heading-into-potential-brain-injury 2026-07-14T17:06:19.000Z daily 0.75 https://www.medxy.ai/news/discriminating-prion-diseases-from-alzheimers-disease-using-plasma-biomarkers-the-crucial-role-of-nfl-p-tau217-ratio 2026-07-14T17:03:13.000Z daily 0.75 https://www.medxy.ai/news/vi/discriminating-prion-diseases-from-alzheimers-disease-using-plasma-nfl-p-tau217-ratio 2026-07-14T17:06:47.000Z daily 0.75 https://www.medxy.ai/news/ja/prion-diseases-from-alzheimers-disease-using-plasma-nfl-p-tau217-ratio 2026-07-14T17:07:08.000Z daily 0.75 https://www.medxy.ai/news/zh/prion-diseases-from-alzheimers-disease-by-plasma-nfl-p-tau217-ratio 2026-07-14T17:07:38.000Z daily 0.75 https://www.medxy.ai/news/mad-mt-score-enhancing-patient-selection-for-mechanical-thrombectomy-in-distal-vessel-occlusions 2026-07-14T17:39:06.000Z daily 0.75 https://www.medxy.ai/news/vi/mad-mt-score-enhancing-patient-selection-for-mechanical-thrombectomy-in-distal-vessel-occlusions-2 2026-07-14T17:39:33.000Z daily 0.75 https://www.medxy.ai/news/long-term-risk-of-hepatocellular-carcinoma-after-clearance-of-hepatitis-b-surface-antigen 2026-07-14T21:52:42.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-risk-of-hepatocellular-carcinoma-after-clearance-of-hbs-antigen 2026-07-14T21:56:03.000Z daily 0.75 https://www.medxy.ai/news/ja/longterm-risk-of-hepatocellular-carcinoma-after-clearance-of-hbs-antigen 2026-07-14T21:55:54.000Z daily 0.75 https://www.medxy.ai/news/reclassifying-pediatric-nafld-insights-from-the-steatotic-liver-disease-framework-in-a-multicenter-nash-crn-study 2026-07-15T08:22:07.000Z daily 0.75 https://www.medxy.ai/news/vi/reclassifying-pediatric-nafld-insights-from-the-steatotic-liver-disease-framework 2026-07-15T08:22:29.000Z daily 0.75 https://www.medxy.ai/news/ja/reclassifying-pediatric-nafld-from-the-steatotic-liver-disease-framework 2026-07-15T08:25:42.000Z daily 0.75 https://www.medxy.ai/news/zh/reclassifying-pediatric-nafld-by-the-steatotic-liver-disease-framework 2026-07-15T08:25:17.000Z daily 0.75 https://www.medxy.ai/news/unraveling-fibroblast-diversity-in-vaginal-wall-prolapse-insights-from-single-nucleus-transcriptomics 2026-07-15T08:24:01.000Z daily 0.75 https://www.medxy.ai/news/vi/unraveling-fibroblast-diversity-in-vaginal-wall-prolapse 2026-07-15T08:26:03.000Z daily 0.75 https://www.medxy.ai/news/ja/fibroblast-diversity-in-vaginal-wall-prolapse-insights-from-single-nucleus-transcriptomics 2026-07-15T08:26:20.000Z daily 0.75 https://www.medxy.ai/news/zh/fibroblast-diversity-in-vaginal-wall-prolapse-from-single-nucleus-transcriptomics 2026-07-15T08:26:33.000Z daily 0.75 https://www.medxy.ai/news/severe-lead-poisoning-during-pregnancy-insights-from-a-19-year-nyc-observational-study 2026-07-15T08:27:18.000Z daily 0.75 https://www.medxy.ai/news/vi/severe-lead-poisoning-during-pregnancy-from-a-19-year-observational-study 2026-07-15T09:09:25.000Z daily 0.75 https://www.medxy.ai/news/ja/severe-lead-poisoning-during-pregnancy-from-a-19-year-study 2026-07-15T09:09:59.000Z daily 0.75 https://www.medxy.ai/news/zh/severe-lead-poisoning-during-pregnancy 2026-07-15T09:10:08.000Z daily 0.75 https://www.medxy.ai/news/harnessing-hrd-testing-and-myc-amplification-to-optimize-parp-inhibitor-use-in-brca-wild-type-high-grade-serous-ovarian-carcinoma 2026-07-15T08:58:18.000Z daily 0.75 https://www.medxy.ai/news/vi/harnessing-hrd-testing-and-myc-amplification-in-parp-inhibitor-use-in-brca-wild-type-high-grade-serous-ovarian-carcinoma 2026-07-15T09:10:43.000Z daily 0.75 https://www.medxy.ai/news/ja/hrd-testing-and-myc-amplification-in-parp-inhibitor-use-in-brca-wild-type-ovarian-carcinoma 2026-07-15T09:11:15.000Z daily 0.75 https://www.medxy.ai/news/zh/hrd-testing-and-myc-amplification-in-parp-inhibitor-use-in-brca-wild-type-ovarian-carcinoma-2 2026-07-15T09:11:32.000Z daily 0.75 https://www.medxy.ai/news/endobarrier-duodenal-jejunal-bypass-liner-a-novel-endoscopic-adjunct-for-improved-glycemic-control-and-weight-loss-in-type-2-diabetes-with-obesity 2026-07-15T09:06:44.000Z daily 0.75 https://www.medxy.ai/news/vi/endobarrier-duodenal-jejunal-bypass-liner-a-novel-endoscopic-adjunct-for-improved-glycemic-control-and-weight-loss-in-t2dm 2026-07-15T09:12:08.000Z daily 0.75 https://www.medxy.ai/news/ja/endobarrier-duodenal-jejunal-bypass-liner-for-improved-glycemic-control-and-weight-loss-in-t2dm 2026-07-15T09:14:08.000Z daily 0.75 https://www.medxy.ai/news/zh/endobarrier-duodenal-jejunal-bypass-liner-for-glycemic-control-and-weight-loss-in-t2dm 2026-07-15T09:14:29.000Z daily 0.75 https://www.medxy.ai/news/enhancing-intraoperative-margin-assessment-in-early-stage-breast-cancer-with-specimen-pet-ct-imaging-insights-from-the-brima-trial 2026-07-15T09:08:56.000Z daily 0.75 https://www.medxy.ai/news/vi/enhancing-intraoperative-margin-assessment-in-early-stage-breast-cancer-with-specimen-pet-ct-imaging 2026-07-15T09:15:09.000Z daily 0.75 https://www.medxy.ai/news/ja/intraoperative-margin-assessment-in-early-stage-breast-cancer-with-specimen-pet-ct-imaging 2026-07-15T09:15:28.000Z daily 0.75 https://www.medxy.ai/news/zh/intraoperative-margin-assessment-in-early-stage-breast-cancer-with-pet-ct-imaging 2026-07-15T09:15:44.000Z daily 0.75 https://www.medxy.ai/news/outcomes-of-colorectal-dysplasia-and-cancer-in-patients-with-psc-ibd-undergoing-liver-transplantation-and-colectomy-insights-from-a-multicenter-study 2026-07-15T09:14:41.000Z daily 0.75 https://www.medxy.ai/news/vi/outcomes-of-colorectal-dysplasia-and-cancer-in-patients-with-psc-ibd-undergoing-liver-transplantation-and-colectomy 2026-07-15T09:16:44.000Z daily 0.75 https://www.medxy.ai/news/ja/outcomes-of-colorectal-dysplasia-and-cancer-in-patients-with-psc-ibd 2026-07-15T09:17:48.000Z daily 0.75 https://www.medxy.ai/news/zh/outcomes-of-colorectal-dysplasia-and-cancer-in-psc-ibd-liver-transplantation-and-colectomy 2026-07-15T09:17:39.000Z daily 0.75 https://www.medxy.ai/news/efficacy-of-recurrent-laryngeal-nerve-reinnervation-in-pediatric-unilateral-vocal-fold-paralysis-insights-from-a-largest-single-center-series 2026-07-15T09:18:08.000Z daily 0.75 https://www.medxy.ai/news/vi/efficacy-of-recurrent-laryngeal-nerve-reinnervation-in-pediatric-unilateral-vocal-fold-paralysis 2026-07-15T09:28:21.000Z daily 0.75 https://www.medxy.ai/news/ja/recurrent-laryngeal-nerve-reinnervation-in-pediatric-unilateral-vocal-fold-paralysis 2026-07-15T09:28:13.000Z daily 0.75 https://www.medxy.ai/news/bridging-subjective-symptoms-and-objective-imaging-in-chronic-rhinosinusitis-impact-of-an-adaptive-sino-nasal-outcome-test 2026-07-15T09:27:39.000Z daily 0.75 https://www.medxy.ai/news/vi/bridging-subjective-symptoms-and-objective-imaging-in-chronic-rhinosinusitis 2026-07-15T09:52:53.000Z daily 0.75 https://www.medxy.ai/news/a-consensus-reference-standard-for-ai-screening-of-age-related-macular-degeneration-what-clinicians-and-developers-need-to-know 2026-07-15T09:33:52.000Z daily 0.75 https://www.medxy.ai/news/zh/a-consensus-reference-standard-for-ai-screening-of-age-related-macular-degeneration 2026-07-15T09:53:16.000Z daily 0.75 https://www.medxy.ai/news/vi/a-consensus-standard-for-ai-screening-of-age-related-macular-degeneration 2026-07-15T09:53:34.000Z daily 0.75 https://www.medxy.ai/news/ja/a-consensus-for-ai-screening-of-age-related-macular-degeneration 2026-07-15T09:53:51.000Z daily 0.75 https://www.medxy.ai/news/artificial-intelligence-smart-eyeglasses-for-the-detection-and-description-of-stationary-objects-a-pilot-feasibility-study 2026-07-15T09:37:49.000Z daily 0.75 https://www.medxy.ai/news/hyperreflective-abnormal-areas-in-middle-retinal-layers-via-en-face-oct-a-novel-biomarker-for-diabetic-retinopathy-risk-stratification 2026-07-15T09:51:47.000Z daily 0.75 https://www.medxy.ai/news/vi/hyperreflective-abnormal-areas-in-middle-retinal-layers 2026-07-15T10:06:02.000Z daily 0.75 https://www.medxy.ai/news/ja/hyperreflective-abnormal-areas-in-middle-retinal-layers-via-en-face-oct-for-diabetic-retinopathy-risk-stratification 2026-07-15T10:06:28.000Z daily 0.75 https://www.medxy.ai/news/zh/hyperreflective-abnormal-areas-in-middle-retinal-layers-via-en-face-oct-for-diabetic-retinopathy-risk 2026-07-15T10:06:53.000Z daily 0.75 https://www.medxy.ai/news/mosaic-loss-of-y-chromosome-links-to-pulmonary-decline-emphysema-and-accelerated-epigenetic-aging-in-men-a-comprehensive-review 2026-07-15T10:10:14.000Z daily 0.75 https://www.medxy.ai/news/vi/mosaic-loss-of-y-chromosome-links-to-pulmonary-decline-emphysema-and-accelerated-epigenetic-aging-in-men 2026-07-15T10:10:24.000Z daily 0.75 https://www.medxy.ai/news/ja/loss-of-y-chromosome-links-to-pulmonary-decline-and-epigenetic-aging-in-men 2026-07-15T10:11:27.000Z daily 0.75 https://www.medxy.ai/news/zh/loss-of-y-chromosome-to-pulmonary-decline-and-epigenetic-aging-in-men 2026-07-15T10:11:41.000Z daily 0.75 https://www.medxy.ai/news/harnessing-precision-medicine-the-aps-consortiums-national-platform-for-phenotyping-ards-pneumonia-and-sepsis 2026-07-15T10:11:44.000Z daily 0.75 https://www.medxy.ai/news/flt3-itd-signaling-drives-immune-evasion 2026-07-15T12:39:18.000Z daily 0.75 https://www.medxy.ai/news/vi/flt3-itd-signaling-drives-immune-evasion-via-pkc-stat1 2026-07-15T12:39:38.000Z daily 0.75 https://www.medxy.ai/news/molecular-mutations-and-cardiovascular-risks-shape-prognosis-in-triple-negative-essential-thrombocythemia 2026-07-15T12:32:13.000Z daily 0.75 https://www.medxy.ai/news/vi/molecular-mutations-and-cardiovascular-risks-shape-prognosis-in-triple-negative-essential-thrombocythemia-2 2026-07-15T12:40:32.000Z daily 0.75 https://www.medxy.ai/news/ja/molecular-mutations-and-cardiovascular-risks-impact-prognosis-in-triple-negative-essential-thrombocythemia 2026-07-15T12:40:58.000Z daily 0.75 https://www.medxy.ai/news/zh/molecular-mutations-and-cardiovascular-risks-shape-prognosis-in-triple-negative-essential-thrombocythemia-3 2026-07-15T12:41:30.000Z daily 0.75 https://www.medxy.ai/news/navigating-dual-resistance-in-extranodal-nk-t-cell-lymphoma-challenges-and-emerging-insights 2026-07-15T12:37:23.000Z daily 0.75 https://www.medxy.ai/news/vi/navigating-dual-resistance-in-extranodal-nk-t-cell-lymphoma 2026-07-15T15:23:21.000Z daily 0.75 https://www.medxy.ai/news/ja/dual-resistance-in-extranodal-nk-t-cell-lymphoma 2026-07-15T15:23:31.000Z daily 0.75 https://www.medxy.ai/news/zh/dual-resistance-in-extranodal-nkt-cell-lymphoma 2026-07-15T15:23:42.000Z daily 0.75 https://www.medxy.ai/news/hypoxia-induced-bach1-elevation-drives-pulmonary-hypertension-via-activation-of-tgfbr2-smad-signaling 2026-07-15T22:14:17.000Z daily 0.75 https://www.medxy.ai/news/vi/hypoxia-induced-bach1-elevation-drives-pulmonary-hypertension-via-tgfbr2-smad-signaling 2026-07-15T22:36:53.000Z daily 0.75 https://www.medxy.ai/news/ja/hypoxia-induced-bach1-elevation-drives-pulmonary-hypertension-via-activation-of-tgfbr2-smad-signaling-2 2026-07-15T22:36:42.000Z daily 0.75 https://www.medxy.ai/news/zh/hypoxia-induced-bach1-elevation-drives-pulmonary-hypertension-via-activation-of-tgfbr2-smad-signaling-3 2026-07-15T22:36:32.000Z daily 0.75 https://www.medxy.ai/news/coronary-artery-calcium-and-statin-allocation-in-the-era-of-prevent-evidence-from-mesa 2026-07-16T07:17:27.000Z daily 0.75 https://www.medxy.ai/news/vi/coronary-artery-calcium-and-statin-allocation-in-the-era-of-prevent 2026-07-16T07:15:05.000Z daily 0.75 https://www.medxy.ai/news/zh/coronary-artery-calcium-and-statin-allocation 2026-07-16T07:16:29.000Z daily 0.75 https://www.medxy.ai/news/temporal-trends-in-oral-anticoagulant-use-and-clinical-outcomes-among-older-adults-with-atrial-fibrillation 2026-07-16T07:17:50.000Z daily 0.75 https://www.medxy.ai/news/vi/trends-in-oral-anticoagulant-use-and-clinical-outcomes-among-older-adults-with-atrial-fibrillation 2026-07-16T07:18:46.000Z daily 0.75 https://www.medxy.ai/news/ja/trends-in-oral-anticoagulant-use-and-clinical-outcomes-with-atrial-fibrillation 2026-07-16T07:19:08.000Z daily 0.75 https://www.medxy.ai/news/zh/trends-in-oral-anticoagulant-use-and-outcomes-with-atrial-fibrillation 2026-07-16T07:20:46.000Z daily 0.75 https://www.medxy.ai/news/non-hdl-cholesterol-and-apolipoprotein-b-measures-and-risk-of-atherosclerotic-cardiovascular-disease 2026-07-16T07:20:30.000Z daily 0.75 https://www.medxy.ai/news/vi/non-hdl-c-and-apolipoprotein-b-measures-and-risk-of-atherosclerotic-cardiovascular-disease 2026-07-16T07:23:25.000Z daily 0.75 https://www.medxy.ai/news/bridging-the-gap-improving-skilled-nursing-facility-to-home-transitions-for-heart-failure-patients 2026-07-16T07:23:45.000Z daily 0.75 https://www.medxy.ai/news/vi/skilled-nursing-facility-to-home-transitions-for-heart-failure-patients 2026-07-16T08:23:55.000Z daily 0.75 https://www.medxy.ai/news/ja/improving-skilled-nursing-facility-to-home-transitions-for-heart-failure-patients 2026-07-16T08:24:14.000Z daily 0.75 https://www.medxy.ai/news/zh/the-gap-improving-skilled-nursing-facility-to-home-transitions-for-heart-failure-patients 2026-07-16T08:25:02.000Z daily 0.75 https://www.medxy.ai/news/efficacy-and-safety-of-osilodrostat-in-adrenal-cushing-syndrome-insights-from-an-international-real-world-study 2026-07-16T08:34:34.000Z daily 0.75 https://www.medxy.ai/news/vi/efficacy-and-safety-of-osilodrostat-in-adrenal-cushing-syndrome 2026-07-16T08:36:25.000Z daily 0.75 https://www.medxy.ai/news/ja/osilodrostat-in-adrenal-cushing-syndrome 2026-07-16T08:36:44.000Z daily 0.75 https://www.medxy.ai/news/zh/osilodrostat-for-adrenal-cushing-syndrome 2026-07-16T09:08:57.000Z daily 0.75 https://www.medxy.ai/news/interleukin-6-receptor-blockade-a-promising-strategy-for-relapse-prevention-in-mog-antibody-associated-disease 2026-07-16T09:08:08.000Z daily 0.75 https://www.medxy.ai/news/vi/interleukin-6-receptor-blockade-for-relapse-prevention-in-mog-antibody-associated-disease 2026-07-16T09:16:38.000Z daily 0.75 https://www.medxy.ai/news/ja/interleukin-6-receptor-blockade-for-relapse-in-mog-antibody-associated-disease 2026-07-16T09:17:14.000Z daily 0.75 https://www.medxy.ai/news/zh/interleukin-6-receptor-blockade-for-mog-antibody-associated-disease 2026-07-16T09:17:32.000Z daily 0.75 https://www.medxy.ai/news/sustained-upper-limb-recovery-with-paired-vagus-nerve-stimulation-two-years-post-stroke-insights-from-the-vns-rehab-trial 2026-07-16T09:16:14.000Z daily 0.75 https://www.medxy.ai/news/vi/sustained-upper-limb-recovery-with-paired-vagus-nerve-stimulation-two-years-post-stroke 2026-07-16T09:18:00.000Z daily 0.75 https://www.medxy.ai/news/ja/sustained-upper-limb-recovery-with-paired-vagus-nerve-stimulation-post-stroke 2026-07-16T09:18:22.000Z daily 0.75 https://www.medxy.ai/news/zh/%E9%85%8D%E5%AF%B9%E8%BF%B7%E8%B5%B0%E7%A5%9E%E7%BB%8F%E5%88%BA%E6%BF%80%E5%8A%A9%E5%8A%9B%E5%8D%92%E4%B8%AD%E5%90%8E%E4%B8%8A%E8%82%A2%E5%8A%9F%E8%83%BD%E6%8C%81%E4%B9%85%E6%81%A2%E5%A4%8D%EF%BC%9Avn 2026-07-16T09:17:43.000Z daily 0.75 https://www.medxy.ai/news/optical-ministroke-in-the-mediodorsal-thalamus-reveals-critical-links-between-sleep-oscillations-and-memory-restoration 2026-07-16T09:56:12.000Z daily 0.75 https://www.medxy.ai/news/vi/optical-ministroke-in-the-mediodorsal-thalamus-links-between-sleep-oscillations-and-memory-restoration 2026-07-16T10:07:30.000Z daily 0.75 https://www.medxy.ai/news/ja/optical-ministroke-in-the-mediodorsal-thalamus-links-sleep-oscillations-and-memory-restoration 2026-07-16T10:07:46.000Z daily 0.75 https://www.medxy.ai/news/zh/optical-ministroke-in-the-mediodorsal-thalamus-links-sleep-and-memory-restoration 2026-07-16T10:08:12.000Z daily 0.75 https://www.medxy.ai/news/targeting-sox9-driven-spem-plasticity-a-new-therapeutic-avenue-to-prevent-gastric-cancer-progression 2026-07-16T10:08:33.000Z daily 0.75 https://www.medxy.ai/news/vi/sox9-driven-spem-plasticity-a-new-therapeutic-avenue-to-prevent-gastric-cancer-progression 2026-07-16T10:22:36.000Z daily 0.75 https://www.medxy.ai/news/ja/sox9-driven-spem-plasticity-to-prevent-gastric-cancer-progression 2026-07-16T10:23:00.000Z daily 0.75 https://www.medxy.ai/news/zh/sox9-driven-spem-plasticity-to-prevent-gastric-cancer 2026-07-16T10:23:17.000Z daily 0.75 https://www.medxy.ai/news/multimodal-c9-66-car-t-cell-therapy-a-promising-advance-in-pancreatic-cancer-treatment 2026-07-16T10:17:13.000Z daily 0.75 https://www.medxy.ai/news/vi/multimodal-c9-66-car-t-cell-therapy-a-promising-advance-in-pancreatic-cancer 2026-07-16T10:23:35.000Z daily 0.75 https://www.medxy.ai/news/ja/c9-66-car-t-cell-therapy-a-promising-advance-in-pancreatic-cancer-treatment 2026-07-16T10:23:52.000Z daily 0.75 https://www.medxy.ai/news/zh/multimodal-c9-66-car-t-cell-therapy-advance-in-pancreatic-cancer-treatment 2026-07-16T10:24:07.000Z daily 0.75 https://www.medxy.ai/news/global-variability-in-non-invasive-testing-accuracy-for-masld-key-findings-from-the-g-masld-study 2026-07-16T10:22:21.000Z daily 0.75 https://www.medxy.ai/news/vi/global-variability-in-non-invasive-testing-accuracy-for-masld 2026-07-16T10:24:49.000Z daily 0.75 https://www.medxy.ai/news/ja/variability-in-non-invasive-testing-accuracy-for-masld 2026-07-16T10:25:10.000Z daily 0.75 https://www.medxy.ai/news/zh/non-invasive-testing-accuracy-for-masld 2026-07-16T10:25:33.000Z daily 0.75 https://www.medxy.ai/news/accuracy-of-menstrual-history-in-assessing-gestational-age-among-adolescents-seeking-abortion-in-england-and-wales 2026-07-16T10:24:29.000Z daily 0.75 https://www.medxy.ai/news/decade-long-outcomes-of-surgical-options-in-rectal-endometriosis-insights-from-a-robust-randomized-trial 2026-07-16T10:28:47.000Z daily 0.75 https://www.medxy.ai/news/vi/decade-long-outcomes-of-surgical-options-in-rectal-endometriosis 2026-07-16T10:30:28.000Z daily 0.75 https://www.medxy.ai/news/ja/long-outcomes-of-surgical-options-in-rectal-endometriosis 2026-07-16T10:31:30.000Z daily 0.75 https://www.medxy.ai/news/zh/outcomes-of-surgical-options-in-rectal-endometriosis 2026-07-16T10:31:22.000Z daily 0.75 https://www.medxy.ai/news/impaired-hearing-and-elevated-systolic-blood-pressure-clinical-markers-for-silent-cerebral-infarcts-following-eclampsia 2026-07-16T14:18:50.000Z daily 0.75 https://www.medxy.ai/news/vi/impaired-hearing-and-elevated-systolic-blood-pressure-clinical-markers-for-silent-cerebral-infarcts 2026-07-16T14:20:59.000Z daily 0.75 https://www.medxy.ai/news/ja/impaired-hearing-and-elevated-systolic-blood-pressure-for-silent-cerebral-infarcts 2026-07-16T14:21:25.000Z daily 0.75 https://www.medxy.ai/news/zh/hearing-and-systolic-blood-pressure-for-silent-cerebral-infarcts 2026-07-16T14:21:42.000Z daily 0.75 https://www.medxy.ai/news/balancing-risk-and-quality-of-life-factors-influencing-timing-of-oophorectomy-after-risk-reducing-salpingectomy-in-brca-previvors 2026-07-16T14:23:04.000Z daily 0.75 https://www.medxy.ai/news/vi/risk-and-quality-of-life-factors-influencing-oophorectomy-after-risk-reducing-salpingectomy-in-brca-previvors 2026-07-16T14:23:44.000Z daily 0.75 https://www.medxy.ai/news/ja/brca-previvor%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E5%8D%B5%E5%B7%A3%E6%91%98%E5%87%BA%E3%81%AE%E6%9C%80%E9%81%A9%E6%99%82%E6%9C%9F%E3%82%92%E3%81%A9%E3%81%86%E8%A6%8B%E6%A5%B5%E3%82%81%E3%82%8B 2026-07-16T14:23:02.000Z daily 0.75 https://www.medxy.ai/news/zh/balancing-risk-and-quality-of-life-factors-in-brca-previvors 2026-07-16T14:24:23.000Z daily 0.75 https://www.medxy.ai/news/harnessing-machine-learning-to-predict-patient-reported-outcomes-after-breast-reconstruction-a-step-forward-in-personalized-surgical-care 2026-07-16T14:24:52.000Z daily 0.75 https://www.medxy.ai/news/vi/machine-learning-to-predict-patient-reported-outcomes-after-breast-reconstruction-a-step-forward-in-personalized-surgical-care 2026-07-16T22:41:16.000Z daily 0.75 https://www.medxy.ai/news/ja/machine-learning-for-breast-reconstruction-a-step-forward-in-personalized-surgical-care 2026-07-16T22:41:37.000Z daily 0.75 https://www.medxy.ai/news/zh/machine-learning-for-breast-reconstruction 2026-07-16T22:42:10.000Z daily 0.75 https://www.medxy.ai/news/robotic-versus-laparoscopic-complex-elective-cholecystectomy-balancing-outcomes-and-costs 2026-07-17T07:24:09.000Z daily 0.75 https://www.medxy.ai/news/vi/robotic-versus-laparoscopic-complex-elective-cholecystectomy 2026-07-17T07:26:04.000Z daily 0.75 https://www.medxy.ai/news/ja/robotic-versus-laparoscopic-elective-cholecystectomy 2026-07-17T07:26:44.000Z daily 0.75 https://www.medxy.ai/news/zh/outcomes-and-costs-of-robotic-versus-laparoscopic-complex-elective-cholecystectomy-balancing 2026-07-17T07:27:31.000Z daily 0.75 https://www.medxy.ai/news/timing-matters-optimizing-additional-surgery-after-noncurative-endoscopic-submucosal-dissection-in-early-gastric-cancer 2026-07-17T07:27:20.000Z daily 0.75 https://www.medxy.ai/news/vi/optimizing-additional-surgery-after-noncurative-endoscopic-submucosal-dissection-in-early-gastric-cancer 2026-07-17T08:11:36.000Z daily 0.75 https://www.medxy.ai/news/ja/additional-surgery-after-noncurative-endoscopic-submucosal-dissection-in-early-gastric-cancer 2026-07-17T08:10:36.000Z daily 0.75 https://www.medxy.ai/news/zh/additional-surgery-at-35-day-after-noncurative-endoscopic-submucosal-dissection-in-early-gastric-cancer 2026-07-17T08:11:27.000Z daily 0.75 https://www.medxy.ai/news/histopathological-impact-of-prolonged-intubation-on-the-trachea-implications-for-early-tracheotomy 2026-07-17T08:12:10.000Z daily 0.75 https://www.medxy.ai/news/vi/histopathological-impact-of-prolonged-intubation-on-the-trachea 2026-07-17T13:02:16.000Z daily 0.75 https://www.medxy.ai/news/ja/impact-of-prolonged-intubation-on-the-trachea-implications-for-early-tracheotomy 2026-07-17T13:02:35.000Z daily 0.75 https://www.medxy.ai/news/zh/impact-of-prolonged-intubation-on-the-trachea 2026-07-17T13:02:55.000Z daily 0.75 https://www.medxy.ai/news/validating-the-adaptive-sinonasal-outcome-test-snot-a-clinically-reliable-tool-for-chronic-rhinosinusitis-assessment 2026-07-17T15:39:46.000Z daily 0.75 https://www.medxy.ai/news/vi/snot-a-clinically-reliable-tool-for-chronic-rhinosinusitis-assessment 2026-07-17T13:03:21.000Z daily 0.75 https://www.medxy.ai/news/ja/validating-the-adaptive-sinonasal-outcome-test-for-chronic-rhinosinusitis-assessment 2026-07-17T13:03:42.000Z daily 0.75 https://www.medxy.ai/news/zh/snot-tool-for-chronic-rhinosinusitis-assessment 2026-07-17T13:04:02.000Z daily 0.75 https://www.medxy.ai/news/bridging-the-gap-geographic-disparities-in-access-to-diabetic-retinopathy-care-across-the-united-states 2026-07-17T11:49:56.000Z daily 0.75 https://www.medxy.ai/news/outcomes-of-nasal-vertical-rectus-belly-transposition-and-lateral-rectus-recession-for-large-exotropia-after-medial-rectus-transection-a-case-series 2026-07-17T13:01:48.000Z daily 0.75 https://www.medxy.ai/news/decoding-the-pulmonary-immune-landscape-in-influenza-insights-from-a-large-scale-single-cell-atlas 2026-07-17T13:04:26.000Z daily 0.75 https://www.medxy.ai/news/vi/decoding-the-pulmonary-immune-landscape-in-influenza 2026-07-17T13:07:11.000Z daily 0.75 https://www.medxy.ai/news/ja/the-pulmonary-immune-landscape-in-influenza 2026-07-17T13:07:26.000Z daily 0.75 https://www.medxy.ai/news/evaluating-riociguat-in-early-pulmonary-vascular-disease-insights-from-the-esra-phase-iia-trial 2026-07-17T13:06:47.000Z daily 0.75 https://www.medxy.ai/news/vi/evaluating-riociguat-in-early-pulmonary-vascular-disease 2026-07-17T13:08:43.000Z daily 0.75 https://www.medxy.ai/news/ja/riociguat-in-early-pulmonary-vascular-disease 2026-07-17T13:08:58.000Z daily 0.75 https://www.medxy.ai/news/zh/riociguat-for-early-pulmonary-vascular-disease 2026-07-17T13:09:23.000Z daily 0.75 https://www.medxy.ai/news/unraveling-mdm4-haploinsufficiency-a-novel-tp53-dependent-mechanism-driving-bone-marrow-failure-syndromes 2026-07-17T13:09:51.000Z daily 0.75 https://www.medxy.ai/news/vi/unraveling-mdm4-haploinsufficiency-driving-bone-marrow-failure-syndromes 2026-07-17T13:12:34.000Z daily 0.75 https://www.medxy.ai/news/ja/mdm4-haploinsufficiency-driving-bone-marrow-failure-syndromes 2026-07-17T13:12:52.000Z daily 0.75 https://www.medxy.ai/news/zh/p53-mdm4-driving-bone-marrow-failure-syndromes 2026-07-17T13:13:20.000Z daily 0.75 https://www.medxy.ai/news/eif4a3-driven-nonsense-mediated-decay-a-novel-regulatory-axis-modulating-aml1-eto9a-dosage-and-clinical-outcomes-in-t821-acute-myeloid-leukemia 2026-07-17T13:11:59.000Z daily 0.75 https://www.medxy.ai/news/vi/eif4a3-driven-nonsense-mediated-decay-modulating-aml1-eto9a-dosage-and-clinical-outcomes-in-t821-acute-myeloid-leukemia 2026-07-17T13:13:51.000Z daily 0.75 https://www.medxy.ai/news/ja/eif4a3-driven-nonsense-mediated-decay-in-t821-acute-myeloid-leukemia 2026-07-17T13:14:22.000Z daily 0.75 https://www.medxy.ai/news/glp-1-receptor-agonists-and-the-risk-of-ischemic-optic-neuropathy-in-type-2-diabetes-evidence-from-a-target-trial-emulation 2026-07-17T13:15:15.000Z daily 0.75 https://www.medxy.ai/news/vi/glp-1-receptor-agonists-and-the-risk-of-ischemic-optic-neuropathy-in-type-2-diabetes-evidence-from-a-tte 2026-07-17T13:16:44.000Z daily 0.75 https://www.medxy.ai/news/ja/glp-1-receptor-agonists-and-the-risk-of-ischemic-optic-neuropathy-in-type-2-diabetes 2026-07-17T13:17:02.000Z daily 0.75 https://www.medxy.ai/news/zh/glp-1-receptor-agonists-and-the-risk-of-ischemic-optic-neuropathy-in-t2dm 2026-07-17T13:17:21.000Z daily 0.75 https://www.medxy.ai/news/quality-cost-and-timeliness-of-cancer-treatment-in-medicare-advantage-versus-traditional-medicare-an-evidence-based-review 2026-07-17T14:47:24.000Z daily 0.75 https://www.medxy.ai/news/vi/quality-cost-and-timeliness-of-cancer-treatment-in-medicare-advantage-versus-traditional-medicare 2026-07-17T14:47:16.000Z daily 0.75 https://www.medxy.ai/news/ja/quality-cost-and-timeliness-of-cancer-in-medicare-versus-traditional-medicare 2026-07-17T14:47:48.000Z daily 0.75 https://www.medxy.ai/news/polypharmacy-challenges-in-older-adults-with-metabolic-dysfunction-associated-steatotic-liver-disease-navigating-care-in-a-high-risk-population 2026-07-17T14:41:27.000Z daily 0.75 https://www.medxy.ai/news/unraveling-the-diarrheal-outbreaks-understanding-cyclospora-and-cryptosporidiosis-in-the-united-states 2026-07-17T14:46:43.000Z daily 0.75 https://www.medxy.ai/news/vi/unraveling-the-diarrheal-outbreaks-understanding-cyclospora-and-cryptosporidiosis 2026-07-17T14:48:04.000Z daily 0.75 https://www.medxy.ai/news/ja/unraveling-the-diarrheal-outbreaks-understanding-cyclospora-and-cryptosporidiosis-in-the-usa 2026-07-17T14:48:28.000Z daily 0.75